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The capability of cells to migrate is vital for many physiological processes, including 
embryogenesis, tissue repair, and immune surveillance. However, cell migration 
becomes fatal when cancer cells acquire invasive properties and set out to conquer new 
metastatic niches in the body. In fact, metastasis is the major cause for cancer mortality. 
Thus, in order to selectively fight metastasising tumour cells, without harming migrating 
host cells, it is of great importance to understand the molecular machineries that 
orchestrate cell motility under different circumstances. 
 
In the course of this thesis, we have unveiled conceptually new mechanisms that 
account for cancer cell migration in 2D and 3D matrix environments. We first discovered 
a novel function for p120RasGAP in the control of integrin recycling. Integrins are 
transmembrane receptors that crucially balance cell adhesion and migration. Their 
function is carefully regulated by ECM ligand-binding activity, but also by their targeted 
trafficking from and to the plasma membrane. We discovered a non-catalytic, 
competitive mechanism by which p120RasGAP replaces the endocytic Rab21 from the 
integrin cargo on early endosomes, which subsequently allows the 1-heterodimer to 
recycle back to the plasma membrane.  
Besides the continuous traffic of integrins, also their localisation needs to be directed to 
dynamic sites of adhesion. We found that in metastasising lung cancer cells, the loss of 
intercellular contacts contributes to increased cell motility by the PKC-dependent 
complex formation between the tight junction protein ZO-1 and 51-integrin. This 
complex localises to the leading edge, where it maintains the lamellipodium and 
supports local Rac1 activation. Thereby, the 51–ZO-1 duo promotes directionally 
persistent migration and may hence fuel the metastatic dissemination of various human 
tumour cells.   
Finally, we shed light on the invasive switch induced by oncogenic c-Met signalling. The 
growth factor receptor is implicated in the progression of most carcinomas to metastatic 
disease. In this study, we identified novel c-Met effectors: RhoA, which promotes pheno-
typic alterations, and Hip1, which mediates c-Met–stimulated 1-integrin endocytosis. 
Moreover, we found that c-Met triggers tumour cell migration in 3D matrices with distinct 
invasion modes, depending on the mechanism of receptor activation.  
 
Collectively, these findings provide new information on the complex molecular networks 
that drive cancer cell migration and invasion. As research progresses, increasing 
knowledge will help us to eventually design potent therapies to combat disseminating 
tumours. 
 








TABLE OF CONTENTS 6 
ABBREVIATIONS 8 
LIST OF ORIGINAL PUBLICATIONS 10 
INTRODUCTION 11 
REVIEW OF THE LITERATURE 12 
1. CELL MIGRATION 12 
1.1 THE BASIC MIGRATORY CYCLE 12 
1.2 A CELL'S SKELETON: ACTIN, MICROTUBULES, AND INTERMEDIATE FILAMENTS 13 
1.3 THE ACTIN CYTOSKELETON UNDER CONTINUOUS RECONSTRUCTION 15 
1.4 MIGRATION DEVICES: LAMELLIPODIA AND FILOPODIA 16 
1.5 THE CONDUCTING FAMILY OF SMALL RHO GTPASES 16 
1.6 CELL POLARISATION - HOW CELLS DECIDE ON A DIRECTION 18 
1.7 TRACTION AND RETRACTION: FINALLY, MOVEMENT! 19 
1.8 MIGRATION MODES: A MATTER OF ENVIRONMENTAL CONSTRAINTS 20 
2. INTEGRIN ADHESION RECEPTORS 23 
2.1 A MULTITASKING FAMILY 23 
2.2 STANDING UP STRAIGHT, LEGS APART: INTEGRIN ACTIVATION 24 
2.3 INTEGRINS AND THEIR LITTLE HELPERS 24 
2.4 SEIZED BY WANDERLUST - INTEGRIN TRAFFICKING 25 
2.5 BACK TO THE FUTURE - INTEGRIN RECYCLING 28 
2.6 SHIFTING GEARS: INTEGRINS IN CELL MOTILITY 30 
3. CANCER CELL INVASION AND METASTASIS 31 
3.1 SOWING THE SEEDS OF CANCER - METASTASIS 31 
3.2 CUTTING THE CORD - EMT 33 
3.3 CANCER INVASION AS A RESULT OF USURPATION AND ADAPTATION 34 
3.4 INVASION DEVICES: INVADOPODIA AND PODOSOMES 36 
3.5 PARTNERS IN CRIME: INTEGRIN AND GROWTH FACTOR RECEPTORS 36 
3.6 THE MANY FACES OF C-MET 38 
AIMS OF THE STUDY 41 







1.  BALANCED INTEGRIN TRAFFICKING - A PREREQUISITE FOR CONTROLLED CELL MIGRATION     
 AND INVASION (I, II, III) 46 
1.1 P120RASGAP CONTROLS INTEGRIN RECYCLING (I) 46 
1.2 INTEGRIN RECYCLING REGULATES CELL MIGRATION (I) 47 
1.3 DIRECTED MIGRATION REQUIRES THE TARGETED TRANSPORT OF INTEGRINS AND ZO-1        
 TO THE LEADING CELL EDGE (III) 48 
1.4 ONCOGENIC C-MET SIGNALLING ENHANCES INTEGRIN TRAFFICKING AND STIMULATES       
 CELL INVASION IN 3D MATRIGEL (II) 49 
2. NOVEL PROTEIN-PROTEIN INTERACTIONS AND FUNCTIONS IN THE CONTROL OF CELL   
 MIGRATION (I, III) 50 
2.1 AN UNEXPECTED NON-GAP FUNCTION FOR P120RASGAP IN THE REGULATION OF 
 VESICULAR TRAFFICKING (I) 51 
2.2 P120RASGAP BINDS INTEGRINS DIRECTLY VIA ITS GAP-DOMAIN AND COMPETES WITH  
 RAB21 (I) 51 
2.3 A NON-CANONICAL PDZ-BINDING MOTIF IN THE 5-INTEGRIN CYTODOMAIN MEDIATES         
 THE DIRECT INTERACTION WITH ZO-1 (III) 52 
2.4 PKC PHOSPHORYLATION OF ZO-1 REGULATES THE SPATIOTEMPORAL COMPLEX 
 FORMATION WITH 51-INTEGRIN (III) 54 
3. SUSTAINED C-MET ACTIVATION INDUCES CANCER CELL INVASION IN COOPERATION WITH    
 RHOA AND HIP1 (II) 55 
3.1  RHOA, A NEW KEY PLAYER DOWNSTREAM OF ONCOGENIC C-MET 55 
3.2 HIP1 MEDIATES C-MET–STIMULATED INTEGRIN ENDOCYTOSIS 56 
DISCUSSION 58 
1. DIFFERENTIAL ROLES OF P120RASGAP DURING CELL MIGRATION 58 
1.1  THE PROMISCUOUS ROLE OF P120RASGAP DURING CELL MIGRATION 58 
1.2 IMPAIRED INTEGRIN RECYCLING: PRO- OR ANTI-MIGRATORY? 61 
1.3 HOW DO RAB21 AND P120RASGAP COOPERATE? 62 
2. NOVEL REGULATORS OF C-MET–INDUCED CANCER CELL INVASION 64 
2.1  A 3D CELL MODEL TO STUDY ONCOGENIC C-MET SIGNALLING 64 
2.2  RHOA, HANDYMAN FOR C-MET–MEDIATED CANCER CELL INVASION 67 
2.3 THE ENIGMATIC ROLE OF HIP1 IN TUMOURIGENESIS AND METASTASIS 68 
3. THE ROLE OF THE 51–ZO-1 COMPLEX DURING CELL MIGRATION 70 
3.1 WHAT GUIDES ZO-1 TO THE LEADING EDGE? 70 
3.2  HOW DOES THE 51–ZO-1 DUO MAINTAIN THE LAMELLIPODIUM? 71 
3.3 POSSIBLE ROLE FOR ZO-1 IN THE NUCLEUS 72 
SUMMARY AND CONCLUSION 73 
ACKNOWLEDGEMENTS 74 
REFERENCES 76 






1D, 2D, 3D One-Dimensional, Two-Dimensional, Three-Dimensional  
AP2 Adaptor Protein 2 
Arf6 ADP-Ribosylation Factor 6 
Arg Abl-Related Gene 
Arp2/3 Actin-Related Protein 2/3  
ATP Adenosine Triphosphate  
BIM I Bisindolylmaleimide I 
CAF Cancer-Associated Fibroblast 
CAT Collective-Amoeboid Transition 
CCP Clathrin-Coated Pit 
CME Clathrin-Mediated Endocytosis 
Col Collagen  
CSF-1 Colony-Stimulating Factor 1 
Csk C-terminal Src inhibitory Kinase 
DAG Diacylglycerol  
DMEM Dulbecco’s Modified Eagle’s Medium  
DN Dominant-Negative 
ECM Extracellular Matrix  
EEA1 Early Endosome Antigen 1 
EGF Epidermal Growth Factor  
EM Electron Microscopy 
EMT Epithelial-Mesenchymal Transition  
ELISA Enzyme-Linked Immunosorbent Assay 
ER Endoplasmic Reticulum  
ERK Extracellular signal-Regulated Kinase 
ESCRT  Endosomal Sorting Complex Required for Transport  
FA Focal Adhesion  
F-actin Filamentous actin  
FACS Fluorescence-Activated Cell Sorting 
FAK Focal Adhesion Kinase  
Fip2 Rab11 Family-Interacting Protein 2 
FBS Fetal Bovine Serum  
FERM Band Four-point-one, Ezrin, Radixin, and Moesin 
Fig. Figure 
FN Fibronectin  
FP Fluorescence Polarization 
G-actin Globular actin  
GAP GTPase-Activating Protein  
GDI Guanine nucleotide Dissociation Inhibitor 
GDP Guanosine Diphosphate 
GEF Guanine nucleotide Exchange Factor  
GFP Green Fluorescent Protein 
GSK Glycogen Synthase Kinase 
GST Glutathione S-Transferase 
GTP Guanosine Triphosphate  
HEK Human Embryonic Kidney 




Hip1 Huntingtin-Interacting Protein 1 
IF Immunofluorescence 
IFs Intermediate Filaments 
IP Immunoprecipitation 
IPTG Isopropyl β-D-1-Thiogalactopyranoside 
kDa Kilodalton  
mAb Monoclonal Antibody  
MAPK Mitogen-Activated Protein Kinase  
MAT Mesenchymal-Amoeboid Transition 
MEF Mouse Embryonic Fibroblast 
MET Mesenchymal-Epithelial Transition 
MMP Matrix Metalloproteinase  
MVBs Multivesicular Bodies 
pAb Polyclonal Antibody  
PAK1 p21-Activated Kinase 1 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction  
PD Pull-Down 
PDGF Platelet-Derived Growth Factor 
PDZ Post-synaptic density 95; Disc large tumour suppressor; Zonula 
occludens 1 
PI, PtdIns Phosphoinositide, Phosphatidylinositol  
PKB / PKC Protein Kinase B/C 
PKD1 Protein Kinase D1 
PLA Proximity Ligation Assay 
PNRC Perinuclear Recycling Compartment 
PTB Phosphotyrosine-Binding  
PTEN Phosphatase and Tensin homologue  
RCP Rab-Coupling Protein 
RFP Red Fluorescent Protein 
RNAi RNA interference 
ROCK Rho Kinase  
RTK Receptor Tyrosine Kinase 
RT-PCR Reverse Transcription PCR  
shRNA Short Hairpin RNA 
siRNA Small-interfering RNA  
SCF Stem Cell Factor 
SSC Squamous Cell Carcinoma 
TAM Tumour-Associated Macrophage 
TCPTP T-Cell Protein Tyrosine Phosphatase 
Tet Tetracycline 
Tiam1 T lymphoma Invasion And Metastasis-inducing protein 1 
TIMP Tissue Inhibitor Metalloproteinase 
TIFF Telomerase-Immortalised Foreskin Fibroblast 
TIRF Total Internal Reflection Fluorescence  
TGN trans-Golgi Network 
WASP Wiskott-Aldrich Syndrome Protein 
WB Western Blot 
WT Wild-Type 
ZO-1 Zonula Occludens 1  
List of Original Publications
 
10 
LIST OF ORIGINAL PUBLICATIONS 
 
This thesis is based on the following original publications, which are referred to in the 




I Competitive Binding of Rab21 and p120RasGAP to Integrins 
Regulates Receptor Traffic and Migration 
Mai A.*, Veltel S.*, Pellinen T., Padzik A., Coffey E., Marjomäki V., 
Ivaska J. (2011) Journal of Cell Biology 
 
II Oncogenic c-Met Signalling Enhances Integrin Trafficking and 
Stimulates Cell Invasion in Cooperation with RhoA and Hip1 
Mai A., Muharram G., Rantala J., Kermorgant S., Ivaska J. 
(manuscript) 
 
III PKCε Regulation of an α5-Integrin–ZO-1 Complex Controls 
Lamellae Formation in Migrating Cancer Cells 
Tuomi S., Mai A., Nevo J., Laine J.O., Vilkki V., Öhman T.J., 




The original publications have been reproduced with the permission of the copyright 
holders. In addition, unpublished data is presented in this thesis. 
 

























Strategies for discovering and developing cancer therapies undergo constant change. 
While the focus was initially on mere killing of rapidly dividing cancer cells (with 
consequent severe side effects on rapidly dividing normal cells), current cancer research 
has evolved into aiming at a more selective targeting of cancer-unique traits. However, 
up to now the success rate for oncology drugs in clinical trials is one of the poorest - 
being more than three times lower than investigational compounds for cardiovascular 
diseases (Kamb et al., 2007). The explanation for the high failure rate may be the 
dynamic genomic changes that drive tumourigenesis and the immensely adaptable 
nature of cancer cells. Moreover, the metastatic spread of tumour cells is largely 
hampering therapeutic interventions and accounts for the majority of cancer deaths 
(Jemal et al., 2011).  
 
Metastasis is a multistep process in which cancer cells acquire several attributes in 
order to disseminate from the primary tumour and establish new neoplastic lesions in 
distant organs. These encompass the gain of growth factor and attachment autonomy, 
as well as the ability to migrate and invade into the surrounding tissue (Bernards and 
Weinberg, 2002). Signals emanating from growth factor and integrin adhesion receptors 
regulate signalling pathways critical for cell adhesion, proliferation, survival, polarity, and 
migration, and are thus often derailed in metastasising cancer cells (Hanahan and 
Weinberg, 2011).  
 
Growth factor receptors are transmembrane receptor tyrosine kinases (RTKs) that, 
following activation by their specific ligands, stimulate signalling cascades important for 
cell survival and proliferation. Signal termination is achieved by receptor dephosphory-
lation and/or internalisation followed by subsequent degradation (Birchmeier et al., 
2003). Moreover, endosomal signalling has been recognised to critically contribute to 
RTK function (Wang et al., 2002). 
Integrins, on the other hand, connect the cellular actin cytoskeleton to the extracellular 
matrix and transmit environmental cues into cellular responses, without possessing any 
intrinsic catalytic activity (Hynes, 2002). Integrin functionality is to a great extent 
controlled by their location. They not only undergo a continuous circuitry of endocytosis 
and recycling back to the plasma membrane, but are also selectively transported to sites 
of dynamic adhesion (Caswell et al., 2009). 
 
Therefore, efficient vesicular trafficking - selective internalisation, directed vesicle transit, 
and targeted recycling - is of tremendous importance for the kinetics and magnitude of 
signal transduction by these cell surface receptors. Small Rab GTPases orchestrate the 
endocytic machinery, and are hence implicated in aberrant integrin and RTK 
functionality (Mitra et al., 2011). Moreover, emerging evidence highlights the significance 
of interactions between integrins and growth factor receptors, both during signalling and 
trafficking, and should be considered for future anti-cancer therapies (Soung et al., 
2010).   
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REVIEW OF THE LITERATURE 
1. Cell Migration 
 
Migration involves the transition of organisms (e.g. amoeba) from one location to an-
other, but also the movement of single cells within complex, multicellular organisms. In 
mammals, the orchestration of cellular migration is especially central for the morpho-
genesis during embryonic development, but also in the adult individual crucial for the 
maintenance of tissue homeostasis, immune surveillance, and wound healing (Ridley et 
al., 2003). Migration-orchestrating proteins are pivotal for the preservation of life and 
health, yet they also contribute to a number of pathological processes including chronic 
inflammatory diseases (such as rheumatoid arthritis and asthma) and tumour metasta-
sis. Moreover, also impaired cell migration results in pathogenic alterations, for instance 
during brain and heart development, leading to epilepsy, mental retardation, or heart 
abnormalities (Horwitz and Webb, 2003).  
Consequently, cell migration is a fundamental and dynamic process that underlies strict 
regulatory mechanisms orchestrated by an array of signalling molecules.  
 
1.1 The Basic Migratory Cycle 
 
Cell movement often arises from environmental, migration-promoting signals, both 
attractive and repulsive, and is classified as either random (-kinesis) or, more often, 
directed (-taxis). Cell motility can be initiated by small molecules (chemotaxis), gradients 
of substrate-bound chemoattractants (haptotaxis) or substrate rigidity (durotaxis), 
mechanical stimuli such as the loss of cell-cell contacts (mechanotaxis), or in response 
to an electric stimulus (electrotaxis) (Petrie et al., 2009).  
Depending on the cell type and the environment, the modes of migration can differ 
greatly. But generally, for a cell to move forward it has to undergo an integrated cycle of 
four basic steps: polarisation, formation of protrusions, adhesion, and retraction of the 
rear (Horwitz and Parsons, 1999). 
As a first response to motogenic signals, cells polarise by establishing an asymmetric, 
well defined front and rear side. At the leading edge, plasma membrane extensions are 
stretched in the direction of migration. These protrusions are mainly driven by the 
remodelling of the actin cytoskeleton and stabilised by the formation of adhesive 
contacts with the underlying substrate. The sites of adhesion are predominantly 
mediated by integrins, a family of cell surface receptors that connect the actin cyto-
skeleton with the surrounding environment. Adhesive contacts mature, as the cell 
migrates, from nascent focal complexes at frontal protrusions to more complex focal 
adhesions underneath the cell body that provide the necessary traction forces for 
forward motion. The retraction of the trailing edge is finally realised by the coordinated 
disassembly of mature focal adhesions at the rear and the contraction of the actin 










Figure 1: A Polarised Migrating Cell.  
The prerequisite for directional migration is the development of a steady front-rear 
polarity. This depends largely on the asymmetric distribution of phosphoinositide phos-
phates (PIPs) and Cdc42. At the cell anterior, Cdc42 and Rac1 generate dynamic actin-
based protrusions that sample the environment and guide the cell towards motogenic 
stimuli. Newly formed adhesion complexes create first adhesion sites with the underlying 
substrate and provide the necessary traction forces. These integrin-regulated structures 
mature into more complex focal adhesions, which orchestrate a wide range of cellular 
signalling cascades and jointly coordinate cell motility. In order to move forward, cells 




1.2 A Cell's Skeleton: Actin, Microtubules, and Intermediate Filaments 
 
How is the polarity in migrating cells established and retained?  
This central event in the initiation of cell motility is realised by the serial recruitment of a 
range of interacting proteins to spatially and temporally restricted locations. All of these 
proteins regulate, in one way or the other, the remodelling of the actin cytoskeleton. 
 
The cytoskeleton acts as a scaffold that supports cellular shape and tension, mediates 
cell-cell junctions, enables membrane organisation and intracellular transport, and thus 
essentially maintains normal cell function (Radulovic and Godovac-Zimmermann, 2011). 
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actin microfilaments, microtubules, and intermediate filaments - and their accessory 
proteins (Ward, 2011). These fibres are built from monomers, and their assembly and 
disassembly is tightly regulating their structure and function. 
 
The family of intermediate filaments (IFs) is encoded by more than 60 genes, giving rise 
to a highly cell type-specific architectural component. Fibrous IFs assemble from 
monomeric IF-proteins that readily self-align in parallel to form coiled-coil dimers. These 
then instantly form anti-parallel tetramers, which further arrange longitudinally into 
extensive filaments with a diameter of about 10 nm (Herrmann et al., 2007). Due to their 
anti-parallel association, IFs lack structural polarity and are more stable than micro-
tubules and actin microfilaments. With these properties, IFs are the major contributor to 
a cell's topology and an important tool to functionally integrate all components of the 
cytoskeleton (Kim and Coulombe, 2007). Apart from their central contribution to the 
cytoarchitecture, the competencies of cytoplasmic IF-proteins have been extended to a 
growing number of other cellular functions. Vimentin, for example, has been shown to 
promote tumour cell migration (Vuoriluoto et al., 2011) and to counterbalance pro-
apoptotic stimuli by protecting ERK kinase from dephosphorylation and thus inactivation 
(Perlson et al., 2006).  
 
Microtubules build a more dynamic filamentous network with intrinsic polarity. They are 
composed of 13 proto-filaments - each assembled of /-tubulin heterodimers - that 
form a hollow cylindrical polymer with a diameter of 25 nm. The nucleation of micro-
tubules starts in the microtubule organising centres (MTOC), typically close to the 
nucleus. Here, -tubulin creates a scaffolding platform for - and -tubulin monomers to 
assemble head-to-tail into proto-filaments with the slow growing (-)-end anchored in the 
MTOC and the faster growing (+)-end elongating towards the cell periphery. During 
polymerisation, both tubulin monomers are bound to GTP which stabilises them. But 
after assembly, only -tubulin remains complexed with GTP, while -tubulin rapidly 
hydrolyses GTP to GDP - resulting in the destabilisation of -tubulin and its dissociation 
from the filament. Growing microtubules therefore constantly undergo cycles of growth 
and shrinkage at their (+)-ends, where -tubulin is exposed. This so called 'dynamic 
instability' is regulated by a range of microtubule-associated proteins (MAPs) that bind 
and stabilise the growing (+)-ends and provide anchorage of microtubule filaments to the 
plasma membrane (Siegrist and Doe, 2007). In addition to MAPs, there is a set of motor 
proteins that use microtubules as tracks for their movement. These include the family of 
kinesins that move towards the (+)-end (Schaap et al., 2011) and dynein that travels 
towards the microtubule (-)-end anchored in the MTOC (Bader and Vaughan, 2010). 
Generally, motor proteins use energy from ATP-hydrolysis to perform mechanical work 
by transporting cargo along microtubules. The great variety of motor proteins is thought 
to enable their cargo specificity and characteristic final destination within the cell (Ward, 
2011).  
 
The actin cytoskeleton forms a highly dynamic and widely branched network. There is 
only one class of motor proteins that uses actin filaments as their tracks: the diverse 
myosin family (Dantzig et al., 2006). Generally, ATP-dependent myosins are classified 
as either conventional or unconventional, of which conventional myosins are found in the 
muscle, where they form filaments and participate in muscle contraction. Unconventional 
myosins are structurally different and perform a larger number of cellular functions, 
including intracellular trafficking - typically transporting cargo towards the elongating end 
of actin fibers.   
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Actin filaments (F-actin) are composed of globular actin subunits (G-actin) that assemble 
linearly into 6 nm wide, double helical polymers. Like microtubules, these filaments 
possess an intrinsic polarity with a so-called barbed (+)-end and a pointed (-)-end. Both, 
F- and G-actin, are bound to an Mg2+ ion and either ATP or ADP. During elongation, 
ATP-bound G-actin adds to the barbed (+)-end of the growing actin filament. ATP-
hydrolysis, occurring during polymerisation, does not influence the rate of polymerisa-
tion, but has, however, a destabilising effect on the elongating actin filament. Once ATP 
is hydrolysed, F-actin is prone to collapse at the barbed end and to a lesser extent also 
at the pointed end. As a consequence, actin filaments simultaneously undergo 
elongation at one end and shrinkage that the other. This 'treadmilling' is only limited by 
the concentration of free monomers in the cytosol: The more subunits collide with the 
growing end, the faster the filament grows (Pollard and Borisy, 2003). Due to these 
kinetic properties, there is a certain concentration of G-actin at which the speeds of 
growth and shrinkage at both ends of an actin filament are equal. In this steady-state, 
the net length of a microfilament does not change.  
In order to maintain a pool of G-actin monomers, allocated for sustaining the steady-
state treadmilling as well as for availability if prompt actin growth is needed, there are 
two cooperating G-actin–binding proteins, which control the accessibility of free actin 
monomers in the cytosol. The first is thymosin-4 (T4) that binds and thereby 
sequesters G-actin by inhibiting its spontaneous de novo nucleation and elongation into 
F-actin. The other one is profilin, a T4-competitor due to its higher actin-binding affinity. 
Also profilin inhibits F-actin nucleation, but unlike T4, profilin catalyses the exchange of 
ADP to ATP and, moreover, allows the attachment of ATP-complexed G-actin to the 
barbed (+)-end. Jointly, profilin and T4 control F-actin elongation and suppress 
spontaneous self-assembly (Pollard and Borisy, 2003).  
 
1.3 The Actin Cytoskeleton under Continuous Reconstruction 
 
As spontaneous self-assembly of monomeric actin is efficiently suppressed, new actin 
filaments arise predominantly from extension or severance of pre-existing filaments, but 
also from stimulated de novo nucleation. In any case, the assistance of actin filament-
nucleating proteins is needed for actin polymerisation. Examples are the Arp2/3 com-
plex, ADF/cofilin, and formins.  
Arp2/3 is a complex comprising the actin-related proteins Arp2 and 3. This complex 
lacks intrinsic activity and is dependent on activation by nucleation-promoting factors 
such as the WASP family (e.g. N-WASP, WAVE) or cortactin. Once activated, Arp2/3 
initiates F-actin elongation by binding to the pointed end of pre-existing filaments and 
stimulating their polymerisation towards the barbed end in a 70° angle to the existing 
filament. Similarly, Arp2/3 achieves branching of actin filaments by binding to the sides 
of F-actin and nucleating a new branch from there (Pollard and Borisy, 2003).  
The elongation of F-actin is terminated by capping proteins such as capping protein (CP) 
and gelsolin. These proteins specifically bind the barbed (+)-end and inhibit both, its 
extension and shrinkage (Takeda et al., 2010). In addition, the hydrolysis of ATP during 
actin polymerisation and the hence released -phosphate (-Pi) are responsible for the 
initiation of debranching. -Phosphate binds to ADF/cofilin, which in turn alters the actin 
filament structure depending on the local cofilin concentration. At low concentrations, 
ADF/cofilin causes the fragmentation of microfilaments. However, high amounts of cofilin 
favour F-actin polymerisation by increasing the number of free barbed (+)-ends and thus 
stimulating the nucleation of new actin filaments (Andrianantoandro and Pollard, 2006). 
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Taken together, although highlighting here only a few, there are a vast number of actin-
associated proteins that cooperatively build, remodel, branch, and organise the highly 
versatile actin cytoskeleton.  
 
1.4 Migration Devices: Lamellipodia and Filopodia 
 
As mentioned earlier, cell locomotion is typically initiated by the formation of actin-rich 
protrusions in the direction of migration. These extensions are distinguished based on 
their shape as either lamellipodia or filopodia. 
The lamellipodium is a broad but thin membrane protrusion, built from a highly branched 
network of short actin filaments. In contrast, filopodia (also called microspikes) are 
comprised of a tightly packed, parallel bundle of actin filaments, forming spike-like 
protrusions that extend from the lamellipodium (Vignjevic and Montagnac, 2008). While 
lamellipodia are thought to be the major engine for locomotion, filopodia are stable, 
sensory structures that probe the environment and guide the moving cell towards the 
migratory attractant (Figure 1). 
Both itinerant organelles generate protrusions by creating a pushing force that spurs the 
plasma membrane forward. This force can be applied because the short and branched 
actin network in lamellipodia is less prone to bending compared to long, flexible 
filaments. The formation and maintenance of this highly dynamic, dendritic network is 
ensured by the cooperation of the Arp2/3 complex, which constantly initiates branching, 
and capping proteins, which limit the length of growing filaments (Huber et al., 2008).  
In contrast, the long and unbranched filaments in filopodia are maintained by elongation 
rather than by branched nucleation. This is ensured by nucleation-promoting factors of 
the Ena/VASP family. Enriched in filopodia tips, these proteins bind and tether barbed 
ends and prevent both capping and branching (Welch and Mullins, 2002). In order to 
also increase stiffness and avoid compression of filopodia, actin filaments are firmly 
bundled by a class of actin cross-linking proteins, such as filamin, -actinin, or palladin 
(Dixon et al., 2008). 
 
1.5 The Conducting Family of Small Rho GTPases 
 
Cell polarisation, in other words the establishment of a distinctive front-rear axis, is to a 
great extent regulated by the Rho family of small GTPases. Proteins of this class belong 
to the superfamily of Ras-related proteins and comprise approximately 20 members, 
including Rho (isoforms A, B, and C), Rac (isoforms 1, 2 and 3) and Cdc42 (Wherlock 
and Mellor, 2002). Most G-proteins of the Ras superfamily contain a C-terminal CAAX-
motif (with C, cysteine; A, alanine; X, any amino acid), which is post-translational 
modified by prenyl transferases. The covalent attachment of prenyl groups, such as 
farnesyl or geranylgeranyl, dictates the localisation of this protein family. Once prenyla-
ted, cytosolic G-proteins are able to reversibly insert the hydrophobic anchor into lipid 
bilayers and to shuttle between the cytosol and membranes (Hoffman and Cerione, 
2000).   
 
Ras-related proteins are regulated by switching between functional distinct GTP- and 
GDP-bound conformations (Figure 2). GTPases generally bind their effector molecules 
when complexed to GTP, but are inactive in the GDP-form. In order to switch between 
these two activation states, they require the help of regulatory proteins. GTPase-
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activating proteins (GAPs) are inactivators that enhance the weak intrinsic GTPase 
activity of small G-proteins, thereby stimulating the hydrolysis of the bound GTP to GDP. 
Guanine nucleotide exchange factors (GEFs) activate GTPases by binding to the GDP-
bound, inactive conformation and subsequently facilitating the release of GDP. Since the 
cellular concentration of GTP is about 10-fold higher than GDP, GTPases promptly bind 
GTP and are active again as soon as GDP is released (Itzen and Goody, 2011). Another 
level of regulation is achieved by multifunctional Guanine nucleotide dissociation 
inhibitors (GDIs), which block the release of bound nucleotides and inhibit GEF activity. 
More importantly, GDIs determine the location of small GTPases within the cell. They 
extract and bind to the membrane-inserted lipid moiety and retain the G-proteins soluble 
in the cytosol. Only GDI dissociation factors (GDFs) can then release the bound 




























Figure 2: The Life Cycle of Small GTPases.  
Small G-proteins are commonly bound to membranes via a hydrophobic lipid anchor, yet 
GDIs can retrieve and retain the GTPases in the cytoplasm. G-proteins are bound to 
either GTP or GDP. For conversion between the two conformations, GAPs and GEFs 
are required. When bound to GTP, GTPases generally recruit signalling molecules and 




Rho-related proteins conduct and orchestrate a multitude of cellular functions, including 
the organisation of the actin cytoskeleton. Rac1 activity is needed for the ruffling 
extension of lamellipodia; Cdc42 is associated with the formation of filopodia; and RhoA 
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into stress fibres, which are crucial for the generation of traction forces during loco-
motion (Ridley, 2001). Due to their distinctive but cooperative functions, the timing and 
location of their activity is carefully balanced along the front-rear axis. 
 
1.6 Cell Polarisation - How Cells Decide on a Direction  
 
In response to external, migration-promoting signals, Cdc42 is activated at the plasma 
membrane, thereby initiating and determining intracellular asymmetry. The importance 
of this direction- sensing function of Cdc42 shows impressively in macrophages. The 
expression of a dominant-negative Cdc42 abolishes their ability to orientate towards a 
chemotactic signal, which results in random migration without any direction (Allen et al., 
1998).   
Localised activation of Cdc42 is achieved by many different pathways, depending on the 
nature of the migratory stimulus (soluble chemokines, loss of cell-cell contacts and so 
on). Often, these signalling cues result in the establishment of a transient phospho-
inositide phosphate (PIP) gradient with a high concentration of PI(3,4,5)P3 and PI(3,4)P2 
at the cell anterior. Phosphoinositides are generated by a network of lipid kinases, 
phosphatases, and phospholipase C (PLC), which orchestrate the interconversion of 
different phosphoinositide species (Bunney and Katan, 2010). PI(3,4,5)P3 and PI(3,4)P2 
are commonly generated by PI3-kinase (PI3K) and degraded by the phosphatase PTEN. 
In response to chemotactic stimuli, the subcellular distribution of both enzymes is hence 
regulated reciprocally: PI3K is recruited to the plasma membrane at the site of the new 
leading edge, whereas PTEN translocates to the sides and the trailing edge (Devreotes 
and Janetopoulos, 2003). Positive feedback loops further amplify the accumulation of 
PI(3,4,5)P3 and PI(3,4)P2 at the front of the cell (Figure 1). The hence originated gradient 
of phosphoinositides recruits PH-domain–containing effector proteins, which, either 
directly or indirectly, lead to the rapid and local activation of Cdc42 at the cell anterior 
(Horwitz and Webb, 2003).  
 
Once activated, Cdc42 stimulates the complex formation of the atypical protein kinase C 
(aPKC) and the polarity proteins Par-3 and -6. This complex activates Rac1 and anta-
gonises RhoA activity at the cell front by simultaneously activating Tiam1, a GEF for 
Rac1, and p190RhoGAP, which inactivates RhoA. In addition, the Par-3/Par-6/aPKC-
complex is activated by Tiam1 in return and inactivated by the RhoA effector kinase 
ROCK (Hurd and Margolis, 2005). Localised Rac1 activity is further achieved by 
PI(3,4,5)P3-sensitive GEFs (Welch et al., 2003) and Cdc42 itself, which stimulates the 
Rac1-GEF PIX via the kinase PAK1 (Cau and Hall, 2005). In brief, spatially restricted 
accumulation of PI(3,4)P2 and PI(3,4,5)P3 as well as transient activation of Cdc42 
determine the direction of migration and dictate the activation of Rac1 (and thus 
lamellipodium formation) at the cell front (Iden and Collard, 2008). At the same time, 
RhoA activity is antagonised as it counteracts the development of advancing extensions. 
This is achieved, for instance, by integrin-stimulated activation of the RhoA inhibitor 
p190RhoGAP. Ligated integrins promote Arg (Abl-related gene) kinase activity, which in 
turn phosphorylates p190RhoGAP. These phosphorylation sites serve as binding epi-
topes for the SH2-domains of p120RasGAP. The p190/p120-complex is consequently 
targeted to the plasma membrane, where p190RhoGAP locally suppresses RhoA 
activity (Bradley et al., 2006).    
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In order to support the generation of a strongly branched lamellipodium at the leading 
edge, actin nucleation-promoting proteins of the WASP family are specifically activated 
at the cell front by PI(3,4,5)P3 and Rac1 (Suetsugu et al., 2006). A high anterior concen-
tration of ADF/cofilin cooperates with the Arp2/3 complex to promote the formation of a 
dendritic actin network (Carlier et al., 1997). In addition, the Abl family of non-receptor 
tyrosine kinases (Abl and Arg) has been shown to reinforce actin dynamics by activating 
multiple signalling pathways, including the stimulation of the WASP family, cortactin, and 
the activation of the Rac1-specific GEF Sos-1 (Bradley and Koleske, 2009).   
 
Besides extensive remodelling of the actin cytoskeleton, also the microtubule network is 
reoriented during cell migration. MT-associating proteins stabilise and anchor MTs at the 
leading edge. Also the MTOC itself is repositioned between the nucleus and the leading 
edge (Gomes et al., 2005). By this, MTs radiate from the MTOC towards the motile front, 
maintain cellular polarity and deliver cargo vesicles in this dynamic region (Siegrist and 
Doe, 2007). In fibrillar one-dimensional (1D) and three-dimensional (3D) environments, 
however, cell motility features an anterior MT bundle and a posterior orientation of the 
MTOC (Doyle et al., 2009). 
 
1.7 Traction and Retraction: Finally, Movement! 
 
Apart from establishing a propulsive front, in order to move forward, migrating cells have 
to translocate their cell body, too. This firstly requires the anchorage of frontal 
protrusions to the underlying substrate or adjacent cells. These sub-membrane sites of 
adhesion function as traction sites and are mainly mediated by transmembrane integrin 
receptors, which link the actin cytoskeleton to proteins of the surrounding extracellular 
matrix (ECM). Additionally, these integrin-rich adhesion plaques serve as mechano-
sensory devices, probing ECM rigidity and transmitting intracellular signals that alter 
cytoskeletal dynamics and adhesion size accordingly (Bershadsky et al., 2003).   
 
Cell-matrix adhesions assemble and mature gradually. The high Rac1 and Cdc42 
activity in the lamellipodium encourages the formation of small, immature adhesions that 
stimulate Rac1 and Cdc42 activation in return. Rac1 and its effector kinase PAK, for 
instance, have been shown to recruit active integrins to the leading edge, thereby 
priming first adhesive contacts at the base of protruding lamellipodia (Kiosses et al., 
1999). The formation of nascent focal complexes starts with integrin aggregation and 
clustering induced by the binding to their specific ECM-ligands. Integrin engagement 
thus results in the recruitment of other adhesion components, either individually or in 
preformed complexes, such as the focal adhesion kinase (FAK) or the multi-domain 
signalling adapter proteins paxillin and tensins (Webb et al., 2002).  
As the anterior protrusions move on, focal complexes either disintegrate or mature into 
focal adhesions (FAs) of bigger size and more complex molecular composition. 
Maturation is induced by increased tensile forces and, in response, stronger RhoA- and 
myosin II-mediated contraction of actin stress fibers (Broussard et al., 2008). The actin 
cross-linking protein -actinin is especially enriched in focal adhesions, reinforcing the 
attachment of microfilaments to the membrane and stabilising mature adhesion sites 
(Webb et al., 2002). FAs are further strengthened by the multi-adapter protein vinculin, 
which integrates most FA components and delays their disassembly (Humphries et al., 
2007).  
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Specialised cell-matrix adhesions evolve from FAs in a more soft and flexible ECM 
environment, with fibronectin being the major component. These so called fibrillar 
adhesions form upon dephosphorylation and subsequent dissociation of paxillin, and are 
typically rich in tensin and fibronectin-binding 51-integrins. Their major function 
includes the formation of fibronectin fibrils underneath the cell body (Zaidel-Bar et al., 
2007).  
 
Maturation of cell-matrix adhesions is antagonised by their turnover, both at the front, 
where new adhesion sites are inherently assembled and disassembled, as well as at the 
rear of the cell, where the trailing edge needs to be retracted (Webb et al., 2002). The 
turnover of FAs is tightly accompanied by the trafficking of integrins that are continuously 
internalised at dissolving adhesions and recycled back to locations of newly forming 
adhesion sites (Caswell and Norman, 2006). Accordingly, loss of the FA-stabilising 
vinculin decreases integrin residency in FAs, and thus facilitates their disassembly 
(Humphries et al., 2007). Similarly, also the FAK-induced dissociation of -actinin 
weakens mature cell-matrix adhesions. Furthermore, activation of the protease calpain 
in response to high spatial calcium levels at the cell rear, leads to the degradation of FA 
components including integrins, FAK, and talin (Huttenlocher et al., 1997). The 
disassembly of adhesions is also largely attributed to microtubules. Direct contact of 
MTs with FAs reduces compulsory tension at sites of adhesion and also enables the 
delivery of yet unknown signalling molecules conducting adhesion dissociation 
(Krylyshkina et al., 2002).   
 
In order to allow the translocation of the cell body, retraction of the trailing edge, and 
finally forward motion, several mechanisms converge to stimulate the myosin II-powered 
contraction of actomyosin bundles. For example, MT-associated RhoA GEFs are known 
to be released from microtubules at the cell posterior, where local RhoA activity, in 
conjunction with its effector kinase ROCK, supports actomyosin contraction (Broussard 
et al., 2008). RhoA-stimulated actomyosin constriction thus causes pulling on mature 
FAs, generating the required traction forces for forward motion, and pulling on weaker, 
nascent adhesions in the trailing edge that hence rip off and are left behind as the cell 
moves on.   
 
In summary, the locomotion of cells is precisely regulated by a lattice of scaffolding and 
signalling proteins, which jointly enable the induction and maintenance of cellular 
polarity, balance adhesion site maturation and turnover, and ultimately allow cell body 
translocation and rear retraction. Maintaining the equilibrium between adhesion and 
protrusion is thereby of particular importance as both too strong as well as too weak 
adhesion dynamics impede migration velocity (Gupton and Waterman-Storer, 2006). 
Small disturbances in this vital process can lead to pathological consequences, including 
the gain of invasive capabilities of malignant tumour cells. 
 
1.8 Migration Modes: A Matter of Environmental Constraints 
 
The migratory cycle described so far, portrays only the basic principles of cellular 
motility. However, cells adjust their migration mode according to specific environmental 
constraints, individual preferences, and functions.  
A number of cells, including neural crest cells, fibroblasts or leukocytes, prefer to move 
as solitary entities. In contrast, epithelial or endothelial cells typically preserve strong 
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cell-cell contacts and migrate collectively as sheet-like cohorts (Farooqui and Fenteany, 
2005). Moreover, some cells move relatively slowly, while others seem to rush forward. 
Fibroblasts migrate at low speed and exhibit distinctive steps of polarisation, protrusion, 
adhesion, and rear release during their locomotion. Fast moving cells, like leukocytes for 
example, display a less obvious separation between those motility stages. They seem to 
move effortlessly with blurred boundaries between adhesion and propulsion (Horwitz 
and Webb, 2003).  
 
The differences between migration strategies become even more evident, when cell 
motility on planar, two-dimensional (2D) surfaces is compared to the movement of cells 
in a three-dimensional (3D) environment. In general, 2D substrates are more rigid and 
evenly distributed. Cells are forced into a dorsal-ventral polarity that allows adhesion 
only at the bottom side (Even-Ram and Yamada, 2005). Additionally, cells on 2D have 
been found to possess elevated Rac1 activity, consequently providing cells with multiple 
peripheral protrusions and thus leading to less directional persistent migration (Pankov 
et al., 2005). In contrast, 3D environments are thought to better mirror in vivo conditions 
in tissues, where cells are entirely surrounded by their ECM-ligands. In vivo, cells 
encounter various complex environments with individual biophysical properties and thus 
diverse migratory challenges, including the interstitial fluid, the connective tissues or the 
highly impermeable basement membrane. Cellular migration strategies therefore 
depend to a great extent on the microenvironment (Poincloux et al., 2011). But 
generally, the migration of cells is believed to be more directed, both in vivo and in the 
lap of artificial 3D surroundings (Even-Ram and Yamada, 2005).  
When cells move within complex 3D environments, they face certain motional limita-
tions. Owing to meshed networks of ECM components and depended on their elastic 
and porous properties, cells have to adapt their shape or employ strategies to remodel 
the ECM by local proteolysis. According to the matrix architecture, cells exploit different 
migration modes to move into and within the ECM (Friedl and Wolf, 2010). Roughly 
schematising, amoeboid and mesenchymal migration modes have been described 
(Figure 3). 
 
Amoeboid migrating cells are typically roundish, lack a stable front-rear polarity and 
stress fibres, and exhibit only weak adhesive cell-matrix contacts, which rapidly turnover. 
In order to move forward, these cells employ RhoA-driven actomyosin contraction in 
conjunction with the dynamic reshaping of their actin cytoskeleton, which allows them to 
simply push and squeeze through pre-existing cavities in the matrix (Friedl et al., 2001). 
Such highly adaptive, adhesion-independent movement is only limited by the size of the 
nucleus that cannot condense any further. However, pore diameters, greatly exceeding 
or falling short of the cell size, already slow down the migration speed (Friedl and Wolf, 
2010). 
 
Mesenchymal migration is characterised by increased attachment and cell-matrix 
interactions of elongated, spindle-like cells. They move in an integrin-dependent manner 
with Rac1-generated anterior protrusions. Unlike on 2D surfaces, these advancing 
extensions do not occur as sheet-like lamellipodia, but as thin cylindrical pseudopodia 
that extend in all three dimensions. Moreover, protease-driven degradation of the 


























Figure 3: Distinct Migration Strategies.  
In complex 3D environments, cells employ two different migration strategies: Amoeboid-
migrating cells lack protease activity, and instead move forward by notable deformation 
of their cell body and actomyosin contraction. In contrast, mesenchymal-migrating cells 
are able to proteolytically degrade the surrounding matrix, thus creating migration tracks. 
In this mode, cells either preserve cell-cell contacts or not. In addition, cells are usually 
guided by a pioneering cell (of either epithelial or fibroblast origin), which expresses 




Cells exploiting the mesenchymal migration mode can move either individually or 
collectively (Figure 3). Individual cells migrate one after another along common trails. 
This so called 'cell streaming' is enabled by the vibrant formation of temporary 
intercellular connections, while tight cell-cell junctions are lacking. In contrast, if strong 
contacts between individual cells are retained, collective locomotion occurs. Collectively 
migrating, multicellular alliances foster a remarkable functional and structural organi-
sation that extends across the entire cohort. Resembling individually moving cells, these 
collectives are governed by a front-rear asymmetry: Leading 'pioneer' cells at the tip fulfil 
exploratory tasks, expose highly dynamic pseudopodia, mediate integrin-dependent 
adhesion, and proteolytically degrade the surrounding ECM. In contrast, 'follower' cells 
at the rear of the assembly predominantly exert cohesion and retractile forces (Friedl 
and Wolf, 2010). Within the group there is a great deal of communication and division of 
tasks that can be genetically determined. During the embryonic development of 
zebrafish, for example, collectively migrating cell cohorts have been shown to display 
clear morphological and functional differences between 'leaders' and 'followers', which 
are attributed to distinctive gene expression profiles (Aman and Piotrowski, 2008). 
Division of tasks within a cell collective also shows in the concerted generation of 
migration tracks. Initial microtracks are formed by pioneering tip cells that employ cell 
surface-located matrix metalloproteinases (MMPs) to degrade the adjacent ECM. The 
path is then broadened by the joint proteolytic activity of the following cells, which cleave 
and re-align ECM fibres impeding the forward motion (Wolf et al., 2007). In addition to 
proteolytic activity, tip cells pave the way and provide guidance for their accompanying 
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cells by secreting basement membrane components (laminins, perlecan, or type IV 
collagen) onto the newly formed microtracks (Friedl and Gilmour, 2009).  
 
In conclusion, cells differ greatly in their migratory strategies, and it is the matrix 
architecture (both, on 2D and in 3D) that predominantly dictates the cellular migration 
mode. The switching between different migration modes is to a great extent regulated by 
the family of integrin cell surface receptors.  
 
2. Integrin Adhesion Receptors  
 
Integrins comprise a large family of transmembrane receptors with versatile functions. 
By integrating cell-matrix adhesion, intercellular interactions, and signal transduction, 
they regulate all cellular key functions: proliferation, differentiation, survival, angio-
genesis, and cell motility. Generally speaking, integrins act as powerful sensors, which 
alter cellular functions in response to environmental cues.  
 
2.1 A Multitasking Family  
 
In vertebrates, integrins form a family of 24 specific /-heterodimers, composed from 
18 - and 8 -subunits that non-covalently associate. Being transmembrane receptors, 
integrins employ their large extracellular domains (about 700 to 1000 residues) to bind 
components of the ECM, and interact with their short intracellular moieties (about 20 to 
50 residues) with the actin cytoskeleton. The cytoplasmic tail is further crucial for integrin 
signalling properties as it interacts with an array of adapter and signalling molecules 
(Luo et al., 2007). Each of the 24 heterodimers possesses characteristic ligand binding 
preferences and signalling properties. Based on the evolutionary relation of the -
subunits, four integrin subfamilies are distinguished: Firstly, the RGD-binding receptors 
(51, v3, and v being named as examples), which recognise and bind 
sequences rich in the amino acid triplet arginine-glycine-aspartic acid (RGD). ECM-
components such as fibronectin or vitronectin contain RGD-motifs and are thus ligands 
for this integrin subfamily. Secondly, there is the subfamily of laminin-binding receptors 
(31, 61, 71, and 64), which mediate adhesion to the basement membrane. 
However, the 4-subunit plays a quite unique role: Unlike other integrins, it possess a 
large cytoplasmic domain that harbours several phosphorylation sites and serves as an 
anchor for intermediate instead of actin filaments (Hynes, 2002). In addition to these two 
highly conserved subfamilies, there are also the collagen-binding integrins and, lastly, 
the more heterogeneous subfamily of residual integrins comprising 41, 91, and 
47, of which the 7-subunit is only expressed in leukocytes, where it recognises cell 
adhesion molecules on the vasculature (e.g. VCAM-1). Collagen-binding integrins are 
11, 21, 101, and 111. A structural characteristic of this subgroup is the 
inserted -domain (also called A-domain) in the  extracellular moiety that generates the 
ligand-binding site. This -domain is also found in -subunits pairing with the leukocyte-
specific 2-integrin, which is important for cell-cell adhesion during leukocyte migration 
across vascular and lymphatic endothelium (Johnson et al., 2009). 
Taken together, integrin cell surface receptors comprise a large family with diverse 
binding partners and thus cellular functions, albeit with varying significance in different 
tissues and cell types. But how are integrins activated and regulated?  
Review of the Literature
 
24 
2.2 Standing up Straight, Legs Apart: Integrin Activation 
 
Unlike transmembrane receptors of the receptor tyrosine kinase (RTK) family, integrins 
do not possess any intrinsic catalytic activity. In order to mediate their functions, they 
rely on the recruitment of a lattice of adapter and signalling molecules that subsequently 
execute integrin-dependent cellular functions (Zaidel-Bar et al., 2007). Nevertheless, 
integrins are far from being just 'passive' linking molecules! One of their most remark-
able features is their ability for bidirectional signal propagation across the plasma mem-
brane (Gahmberg et al., 2009): Binding of their extracellular ligands induces conforma-
tional changes that are converted into intracellular signalling cascades and responses 
(the so called 'outside-in' signalling). In contrast, also intracellular proteins can either fuel 
or impede integrin activity, thereby altering receptor affinity towards ECM-ligands and 
thus fine-tuning integrin functions such as cell adhesion or migration ('inside-out' 
signalling).    
When resting, integrins obtain a bent conformation with their N-terminal head-domains 
facing the plasma membrane and their two subunits being in close proximity. This 
closed, inactive configuration is stabilised by a salt bridge between the - and -
cytoplasmic tails ('legs') in vicinity to the plasma mem-brane (Hughes et al., 1996). 
Activation is achieved by either ligand binding to the extracellular domain or intracellular 
regulators that bind to the cytoplasmic integrin tail - both mechanisms leading to 
straightening and spatial separation of the 'legs'. With the cytoplasmic tails being apart, 
effector-binding epitopes are exposed and downstream signalling is enabled (Kim et al., 
2003).  
 
2.3 Integrins and Their Little Helpers 
 
The actin-binding protein talin has been recognised to actively participate in integrin 
('inside-out') activation (Tadokoro et al., 2003). In response to pro-migratory stimuli, but 
not exclusively, talin is recruited to the plasma membrane by RIAM, a Rap1 effector. 
This interaction exposes an integrin-binding site on the N-terminal tripartite FERM- 
(band 4.1, ezrin, radixin, and moesin) domain of talin, which contains a phosphotyrosine-
binding (PTB)-domain. This PTB-domain is found in several integrin-accessory proteins, 
allowing the interaction with either of the two conserved NPxY-motifs (N, aspartic acid; 
P, proline; x, any amino acid; Y, tyrosine) on the integrin -cytoplasmic tail (Calderwood 
et al., 2002). A second hydrophobic interaction site of talin within integrin membrane-
proximal residues additionally releases the inhibiting salt bridge between the 'legs', 
ultimately leading to integrin priming. This dual interaction with integrins is unique to talin 
and might explain why other PTB-containing proteins bind the -NPxY-motif, but fail to 
activate integrins (Wegener et al., 2007). However, talin has recently been found to not 
solely transmit integrin activity. Members of the kindlin protein family also contain FERM-
domains, with which they bind integrin -tails and activate the adhesion receptors in 
cooperation with talin (Moser et al., 2008; Montanez et al., 2008).  
 
Once activated, integrins bind their ECM-ligands and, in synergy with mechanical stress 
applied by the interactions with the rigid matrix, cluster to form nascent focal complexes 
(Ali et al., 2011). This cooperative integrin stimulation leads to the activation of Src, a 
non-receptor tyrosine kinase. Src and its inhibitor Csk (C-terminal Src inhibitory kinase) 
are constitutively bound to the -integrin tail. Receptor clustering results in the 
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dissociation of Csk and ultimately to activation of Src, which stimulates several down-
stream signalling pathways, reinforcing lamellipodia formation at the protruding front. 
Furthermore, Src promotes activation of the FA key regulatory protein FAK and phos-
phorylates the -NPxY-motif itself, leading to the dissociation of talin, and hence to focal 
adhesion maturation (Arnaout et al., 2007). FAK serves as an integrating adapter and 
signalling protein that promotes focal adhesion formation and turnover by recruiting 
multiple downstream targets, implicated in cell migration orchestration. FAK signalling is 
terminated by association of SOCS proteins (suppressors of cytokine signalling), 
initiating FAK polyubiquitination and subsequent degradation (Liu et al., 2003). In 
addition, FAK is dephosphorylated by integrin-recruited and -activated protein tyrosine 
phosphatases such as Shp2 (von Wichert et al., 2003) or PEST (Zheng and Lu, 2009). 
Src-mediated phosphorylation of the NPxY-motifs on the -tail, as well as integrin phos-
phorylation by other specifically recruited kinases, generates characteristic binding 
epitopes for other integrin accessory proteins - ultimately leading to the assembly of 
signalling platforms at focal adhesion sites (Legate et al., 2009). Moreover, phos-
phorylation of NPxY-motifs on -cytodomains has been linked to the binding of Dok1, 
which has an inactivating effect on integrins (Anthis et al., 2009).   
 
In summary, integrins excel not only in their bidirectional signalling capabilities and their 
mechano-sensory function, they also integrate a multitude of vital signalling cascades. 
Each heterodimer thereby activates a characteristic set of targets (Wu et al., 2008). 
Remarkably, ligand-bound integrins compete against each other, actively inhibiting their 
mutual activation and downstream signalling. Collagen-bound 21-integrin, for 
instance, restrains signalling of 51- and v3-integrins via protein kinase A (PKA) 
activation. Conversely, PKC recruitment by fibronectin-ligated 51 suppresses 21-
integrin activation (Orr et al., 2006). These properties, in conjunction with an extensive 
network of more than 150 accessory proteins (Zaidel-Bar et al., 2007), make integrins 
powerful regulators, which are crucial for a vast number of cellular functions, including 
cell motility.   
 
2.4 Seized by Wanderlust - Integrin Trafficking 
 
Beyond regulation of ligand binding and activation at the cell surface, integrin activity is 
further controlled spatiotemporally: They travel steadily between the plasma membrane 
and various vesicular organelles in the cytosol.   
The signalling of many cell surface receptors, including growth factor receptors, is 
terminated by internalisation into multivesicular bodies (MVBs), followed by degradation 
in lysosomes. For this purpose, cargo proteins are tagged by ubiquitination and sorted 
into degradation-destined MVBs by the ESCRT (endosomal sorting complex required for 
transport) machinery (Williams and Urbe, 2007). Also 51-integrin has been found to 
be subjected to this degradative pathway. Following fibronectin-binding, the ligated 
integrin is ubiquitinated at its 5-subunit, endocytosed into the cytosol together with FN, 
where it is recognised by ESCRT proteins and finally sorted to lysosomes (Lobert et al., 
2010). However, most integrin receptors evade this degradative fate and, instead, 
experience a constant flux of internalisation into endosomal compartments and recycling 
back to the plasma membrane. This selective endo/exocytic circuitry is to a great extent 
regulated by the large family of small Rab GTPases. Like other small G-proteins, Rabs 
switch between an active GTP- and an inactive GDP-bound conformation, controlled by 
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GEFs and GAPs (Figure 2). Rab GTPases are post-translational isoprenylated by 
covalent attachment of a geranylgeranyl group to a C-terminal cysteine residue. Owing 
to this hydrophobic lipid anchor, Rab proteins are reversely bound to membranes of 
specific cellular organelles. The targeting of Rabs to their designated membranes is 
achieved by GDIs that retrieve Rab GTPases from membranes, retain them in the 
cytosol and, on demand, recycle them back to their target membranes (Pfeffer, 1994).  
 
Generally speaking, Rab proteins and their regulators coordinate intracellular trafficking 
by ensuring cargo specificity and supervising fusion organelle identity. Of the more than 
60 Rab GTPases in humans, some have general functions, while others operate in a cell 
type-specific manner (Mitra et al., 2011). However, a salient feature of all Rab proteins is 
their localisation to distinct organelles. Commonly, a certain Rab GTPase executes a 
particular step during vesicular traffic, while the cargo proceeds consecutively from one 
Rab-compartment to the next. Rab5, for example, localises specifically to the plasma 
membrane, caveosomes, and clathrin-coated vesicles, and stimulates their transport to 
early, sorting endosomes, where it tethers exclusively to the early endosome antigen 1 
(EEA1). In contrast, Rab4 and Rab11 mediate recycling from early endosomal 
compartments, while Rab7 promotes maturation of vesicles into late endosomes and 
fusion with the lysosomes. Rab9, on the other hand, has been shown to guide late 
endosomes retrogradely to the trans-Golgi network (TGN). Despite this segregation of 
functions, some Rab proteins still localise to the same endosomal organelle, but 
compartmentalise the membrane into distinct microdomains. Late endosomes contain 
characteristic mosaic-like patterns for Rab7 and Rab9 (Stenmark, 2009). Similarly, 
Rab4, Rab5, and Rab11 colonise early and recycling endosomes in various, yet 
distinctive combinations (Sonnichsen et al., 2000). Each of these organelles 
corresponds to a specific endosomal compartment, gradually sorting and handing cargo 
on through the trafficking machinery till the final destination (Zerial and McBride, 2001).   
 
The guidance of integrins through the complex network of trafficking organelles is 
thoroughly controlled and greatly dependent on both the integrin heterodimer and cell 
type in question. Two main routes are used by integrins to enter the cell: clathrin-
mediated endocytosis (CME) and clathrin-independent internalisation (Figure 4). CME is 
characterised by the cytoplasmic protein clathrin that is recruited to the plasma mem-
brane, where it assembles into clathrin-coated pits (CCPs). Owing to a set of clathrin 
adapter proteins (AP2, Dab, Numb, and Hip1 being named representatively), these pits 
contain specifically selected cargo proteins. Sequential recruitment of clathrin co-factors 
then leads to the budding of pits, and subsequently the GTPase dynamin enables the 
pinching-off from the membrane. In the cytosol, clathrin-coated vesicles swiftly lose their 
clathrin coat and progress to early sorting endosomes (Ramsay et al., 2007). Several 
cell surface molecules, including growth factor receptors, predominantly enter the cell 
via CCPs; whereas, for a long time, integrins have been believed not to favour this entry 
route. However, a growing number of integrins have recently been recognised to 
internalise clathrin-dependently, including 11, 2, 51, and v3. 1- and 3-
integrins directly interact with the clathrin adapter proteins disabled 2 (Dab2) and Numb, 
which recognise the cytoplasmic NPxY-motif in integrin -tails by their PTB-domains 
(Caswell et al., 2009). The -integrin tail contains, moreover, two membrane-distal, 
conserved NxxY-motifs, which interact directly with the clathrin adaptor protein 2 (AP2). 
Integrin mutants carrying phenylalanine substitutions within these motifs (1YYFF) fail to 
internalise 1-integrins through the clathrin-dependent endocytosis route (Pellinen et al., 
2008).  































Figure 4: Integrin Trafficking Routes.  
Integrins undergo a constant flux of endocytosis and recycling - lysosomal degradation 
occurs rarely. Endo/exocytic traffic is generally regulated by Rab GTPases that mediate 
distinct transport steps (see text for details). Integrins typically enter the cell by clathrin-
mediated endocytosis or clathrin-independent, lipid raft-regulated caveolae. Following 
growth factor stimulation, rapid uptake of integrins arises also from macropinocytosis at 
circular dorsal ruffles. The return of integrins to the plasma membrane happens through 
the fast, Rab4-mediated or the slow, Rab11/Arf6-regulated route. The decision on the 
recycling path is made in the early, sorting endosome (EE) by a number of signalling 
proteins according to external stimuli. (CCP, clathrin-coated pits; Cav1; caveolin 1; FA, 
focal adhesion; PNRC, perinuclear recycling compartment; RE, recycling endosome; 
MVB, multivesicular bodies; Vim, vimentin) 
 
 
Most integrins, however, have been found to internalise via clathrin-independent yet 
dynamin-dependent caveolar endocytosis. This route sprouts from cholesterol-rich lipid 
rafts on the plasma membrane, which enrich cargo proteins due to distinct biophysical 
and biochemical properties. Caveolae are small, uncoated invaginations within these 
lipid rafts. To date it is not fully understood how caveolae bud from the plasma mem-
brane, albeit dynamin-dependent abscission is required. Furthermore, phosphorylated 
caveolin 1 has been found to stimulate caveolae internalisation. Phospho-caveolin 1 is 
usually retained by integrins at focal adhesion sites. Upon detachment or FA 
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induces their budding from the plasma membrane. Following re-attachment, integrins 
sequester phospho-caveolin 1 in FAs again and thereby impede their own 
internalisation at sites of adhesion (del Pozo et al., 2005). After abscission, caveolae 
are first delivered to caveolin 1-containing endosomes, termed caveosomes, and then 
proceed from there to early and recycling endosomes (Nichols, 2003). 21-Integrin 
has been found to enrich in caveolae following antibody- or echovirus-1–induced 
integrin clustering. This process depends on PKC activation and the 2-integrin 
subunit, as clustering of v supported endocytosis into CCPs (Upla et al., 2004). PKC 
has been realised to be of general importance for the dynamin-dependent 
internalisation of 1-integrins (Ng, 1999). The kinase directly binds to the conserved 
NxxY-motifs in the -tail of activated integrins and authorises their endocytosis into 
caveosomes (Parsons et al., 2002).  
 
Interestingly, some integrin heterodimers are promiscuous in their choice of an inter-
nalisation route.v3-Integrin, for example, is optionally recruited to either caveolae or 
CCPs (Caswell et al., 2009). Similarly, 51 generally enters the cell in an NxxY- and 
clathrin-dependent manner. However, if this entry route is blocked by either expression 
of mutant 1YYFF or the clathrin inhibitor monodansylcadaverine, 51-integrins are 
internalised Rab21-dependently (Pellinen et al., 2008). Rab21, on the other hand, 
interacts with the conserved membrane-proximal GFFKR sequence that is common to 
most integrin -subunits (Pellinen et al., 2006). Resembling Rab5 (both GTPases 
belonging to the Rab5 subfamily), Rab21 critically regulates the endocytosis of several 
integrins, including 11, 21, and 51, and controls the movement of early endo-
somes along microtubules (Simpson et al., 2004; Pellinen et al., 2006). The general 
importance of Rab21-mediated integrin trafficking reflects in the finding that Rab21 not 
only critically regulates cell migration, but also controls cytokinesis, a late stage of 
mitosis, in which the two daughter cells divide. During cytokinesis, Rab21-vesicles target 
integrin cargo to and from the cleavage furrow, specifically guiding integrins to their sites 
of action (Pellinen et al., 2008). 
 
Another clathrin-independent internalisation mechanism, which has not been discussed 
thus far, is macropinocytosis emanating from circular dorsal ruffles. These structures are 
built from actin filaments and form temporarily at the dorsal plasma membrane in 
response to stimulation with growth factors, including EGF, PDGF, and HGF (Buccione 
et al., 2004). Abscission of these large fluid-filled macropinosomes supposedly requires 
action of Rab5, dynamin, and cortactin. Integrins were found to rapidly traffic via this 
pathway following PDGF-stimulation (Gu et al., 2011).  
 
2.5 Back to the Future - Integrin Recycling 
 
Irrespective of the internalisation route, cargo proteins enter the early, sorting endo-
some, where their final destiny is decided: transport to lysosomes for eventual 
degradation or recycling back to the plasma membrane for re-use (Ramsay et al., 2007). 
Integrins are usually designated for the latter fate.  
 
Receptor recycling occurs along two different routes: A Rab4-mediated, fast recycling 
path (the 'short-loop') that recycles cargo directly from the early endosome back to the 
plasma membrane; or a Rab11-controlled, slow recycling pathway (the 'long-loop') 
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that guides cargo through the perinuclear recycling compartment (PNRC) before 
returning it to the plasma membrane (Ramsay et al., 2007). Which recycling route is to 
be chosen, is tightly orchestrated according to cellular and environmental cues 
(Figure 4). 
 
Most integrins transit the PNRC and recycle through the Rab11-dependent long-loop, a 
process that requires PKB/Akt activation and consequent GSK-3 (glycogen synthase 
kinase) inactivation (Roberts et al., 2004). Moreover, the return of 1-integrins to the 
plasma membrane is also dependent on PKC-mediated phosphorylation of the IF-
protein vimentin, which triggers the release of recycling vesicles from the tethering 
filaments (Ivaska et al., 2005).  
 
In cooperation with Rab11, also the ADP-ribosylation factor 6 (Arf6) has been found to 
regulate the slow recycling of integrins via the PNRC (Powelka et al., 2004). Both 
GTPases exert their recycling function by recruiting a number of effector proteins. 
Rab11, for example, binds to the adapter protein Fip2 (Rab11 family-interacting protein 
2) that bridges Rab11 and its cargo vesicle to the motor protein myosin Vb - hence 
allowing vesicular movement along actin filaments (Hales et al., 2002). Also another 
member of the Fip family, the Rab-coupling protein (RCP), has been shown to be crucial 
for the recycling of 1-integrins (Caswell et al., 2008). In contrast, Arf6 collaborates with 
ACAP1, which is not only an inactivating GAP for Arf6, but also its downstream effector. 
As a component of the coat complex, ACAP1 sorts the cargo protein at the recycling 
endosome. When phosphorylated by Akt, ACAP1 specifically binds to endosomal 1-
integrin and thereby assigns it for recycling from the PNRC to the plasma membrane (Li 
et al., 2005). 
 
Another member of the Rab11 subfamily, thus promoting recycling from the PNRC, is 
Rab25. But unlike other Rab11 isoforms, Rab25 expression is restricted to cells of 
epithelial origin. Rab25 has been shown to directly bind to the cytoplasmic tail of 1-
integrins and to direct them to the tips of invading pseudopodia. Interestingly, the 
migration-stimulating effect of Rab25 could only be observed in a 3D environment, but 
not on planar surfaces (Caswell et al., 2007). 
 
However, migrating cells are able to bypass the long recycling route. In order to rapidly 
supply nascent focal contacts with integrin adhesion receptors, and following PDGF-
stimulation, v3, but not 51, is diverted from the longer Rab11-route to the short 
Rab4-dependent path, triggering recycling directly from early endosomes (Roberts et al., 
2001). This selective redirecting of v3 is achieved by direct association of the protein 
kinase D1 (PKD1) with the 3-cytoplasmic domain, which then enables the quick 
delivery of v3 to nascent focal complexes at the advancing lamellipodium (Woods et 
al., 2004). Moreover, if the short-loop recycling path is blocked by expression of a 
dominant-negative Rab4, v3 still returns to the plasma membrane by taking the 
Rab11-route, but the integrin is no longer targeted solely to the cell front (Jones et al., 
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2.6 Shifting Gears: Integrins in Cell Motility 
 
Endocytic trafficking is essential for the generation and maintenance of cell polarity. The 
asymmetric distribution of migration-determining proteins, including integrins, arises from 
the targeted transport of vesicles into defined intracellular regions. Integrins are 
generally delivered to the advancing lamellipodium. This is achieved by increased 
internalisation and recycling rates at the cell front, while at the trailing edge trafficking is 
slowed down (Jones et al., 2006). Moreover, also the lamellipodium itself plays a role in 
concentrating signalling molecules at the leading edge by simply restricting their lateral 
diffusion (Weisswange et al., 2005).  
 
The spatiotemporal regulation of endosomal trafficking not only restricts integrins to 
defined subcellular compartments, but also affects their downstream signalling and thus 
cellular responses. It has been shown that integrins mutually alter their itinerary routes 
and, as a result, impede their signalling. The best studied example is the differential 
recycling of v3 and 51 that leads to a switch in the migration mode (White et al., 
2007). Cells move directionally persistently, when v3 recycles rapidly by taking the 
PDGF-stimulated and Rab4-mediated short-loop. Being targeted to the leading edge, 
v3 signalling supports local Rac1 activation, provides high levels of ADF/cofilin, and 
thus drives the extension of a single prominent lamellipodium (Danen, 2009). Besides 
provoking localised Rac1 activation, v3 antagonises simultaneously the recycling of 
51-integrin - possibly by sequestering RCP, a Rab11-adapter protein that specifically 
recycles 1-integrins (Caswell et al., 2008). 51 also mediates cell adhesion to fibro-
nectin, but unlike v3 it inhibits cofilin and strongly activates RhoA signalling. Thus, 
cells that express only 51 migrate rapidly but randomly owing to multiple peripheral 
protrusions in various directions (Danen, 2009). Similarly, if v3-integrin is inhibited, its 
51-antagonising function is abrogated, resulting in increased recycling of this integrin 
and thus random cell motility (White et al., 2007). Remarkably, this diminished persistent 
migration was only observed on 2D surfaces, whereas RCP-mediated recycling of 51-
integrin increased the directed migration of cells into a fibronectin-rich 3D matrix 
(Caswell et al., 2008). 
In addition to striking differences of both RGD-binding receptors in their preference to 
activate either Rac1- or RhoA-signalling, v3 and 51 further differ in the cell-matrix 
adhesions they support - with the first promoting static and the latter highly dynamic 
adhesions (Truong and Danen, 2009). Interestingly, it has been found that both integrins 
bind immobilised fibronectin equally well, but only 51 is additionally able to bind 
soluble fibronectin. It has been proposed that binding of this free fibronectin fraction 
(possibly secreted by the cell itself) competes and thus diminishes the interaction of 
51 with the immobilised ligand in the ECM - hence making these cell-matrix 
adhesions more pliable and dynamic (Truong and Danen, 2009).     
Taken together, integrins shift the gears in cell motility by adjusting distinct migration 
modes according to the environmental and cellular requirements. On 2D, 1-integrins 
generally support random migration, while 3-receptors promote directed motility.  
 
It is further evident that an asymmetric activation of the opposing GTPases Rac1 and 
RhoA plays an essential role in the regulation of migration. But balancing these two is 
not only achieved by differential activation by integrins. It has been found that inactive 
Rac1 itself is retrieved by Rab5- and clathrin-dependent internalisation and guided to the 
early endosome, where Tiam1 (T lymphoma invasion and metastasis-inducing protein 
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1), a GEF protein, stimulates the exchange of GDP for GTP (Palamidessi et al., 2008). 
Active Rac1 is subsequently targeted through the Arf6-mediated recycling route to the 
plasma membrane at the cell anterior. In addition to this CME-mediated mechanism, 
Rac1 can also rapidly localise to the protruding front via macropinosomes emanating 
from circular dorsal ruffles following growth factor stimulation. Also integrins are known 
to be recruited to these ruffles, internalised and instantly recycled to sites of newly 
forming adhesion complexes (Gu et al., 2011).  
 
In summary, integrin adhesion receptors comprise a large and diverse family exerting 
functions well beyond cell attachment regulation. With their unique ability for bidirectional 
signal transduction, integrins adapt cellular functions, such as survival and proliferation, 
according to environmental cues and simultaneously modify interactions with the 
environment, including adhesion and migration, corresponding to cellular needs. The 
ability to mutually interfere with their trafficking and signalling further adds diversity to 
integrin functions. And it is just this proficiency of integrins that makes them susceptible 
for exploitation in various pathologies, ranging from cardiovascular, dermatologic, and 
musculoskeletal disorders up to carcinogenesis (Moschos et al., 2007; Wehrle-Haller 
and Imhof, 2003).     
 
3. Cancer Cell Invasion and Metastasis 
 
Integrins and associated signalling cascades are involved in nearly all steps of carcino-
genesis, the transformation of a normal cell into a neoplastic cancer cell. During the 
progression into a malignant tumour, cells acquire gradually a set of distinctive and 
complementary capabilities - summarised by Hanahan and Weinberg as the hallmarks 
of cancer (Hanahan and Weinberg, 2011). These comprise: sustained and excessive 
proliferation; evasion of apoptosis, growth suppressors, and immunological destruction; 
induction of angiogenesis; gain of replicative immortality; alteration of the cellular energy 
metabolism; as well as invasion and metastasis - all of which are favoured by the 
inherent genomic instability of cancer cells and the occasional inadvertent support from 
immune cells during inflammatory defence reactions. 
 
3.1 Sowing the Seeds of Cancer - Metastasis 
 
The spread of cancer cells from the primary tumour to other, distant sites in the body is 
the most common lethal consequence of cancer. Difficulties in the systemic treatment 
and cure arise from the great biological heterogeneity of cancer cells in the primary 
tumour and in metastases, and also from responses of the host, which often are 
inadvertently tumour supporting (Fidler, 2003). Cancer cells constantly escape from the 
primary tumour, but seldom succeed to colonise to distant organs. The explanation for 
this is that the process of metastasis requires a cascade of discrete steps, all of which 
demand specific capabilities (Figure 5). Most cancer cells are insufficient in one or more 
of these steps, resulting in immediate failure to metastasise.       
 
The relentless growth of a primary tumour demands an enormous supply with nutrients 
and oxygen as well as the removal of by-products. These needs can no longer be 
satisfied by simple diffusion if a tumour mass exceeds 1 to 2 mm in diameter. The 
resulting deficient oxygen supply (hypoxia) is most often the driving force for tumour 
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cells to initiate angiogenesis and lymph-angiogenesis in the surrounding host tissue and 
to establish an extensive network of capillaries (Lu and Kang, 2010). The metastatic 
cascade then begins with local invasion into the surrounding stroma and intravasation 
into lymphatic or blood vessels. In many cases, local lymph nodes are the primary target 
for metastatic colonisation (Psaila and Lyden, 2009). In the blood circulation, shear 
stress and the lack of attachment provide a hostile environment that is fatal for most 
cancer cells. The few that survive, escape from the vessels, transit the endothelium into 
the neighbouring tissue, and form small micrometastasis. Expansive proliferation of 
these lesions into macroscopic tumours, survival in the new, foreign microenvironment, 
neovascularisation, and evasion of immunological defence mechanisms, ultimately 
result in the settlement of a metastasis at a distant organ - being capable of seeding 
metastases itself (Fidler, 2003).  
 





























Figure 5: The Metastatic Cascade.  
A metastasis-competent cancer cell must be a jack of many trades in order to success-
fully colonise a new site in the body. The metastatic process requires distinctive skills 
that enable the cancer cell to invade various tissue environments, to penetrate vessel 
walls, to endure the hostile milieu in the circulation, and, finally, to grow and survive in 
the new environment (see text for details). Thus, most cancer cells actually fail to 
metastasise. However, the few cells that possess these versatile requirements (usually a 
population of cells that complement each other’s capabilities) are hard to eradicate and 
often resistant to conventional systemic therapies.   
Primary Tumour
  (Proliferation)







Review of the Literature
 
33 
The success rate of planting a metastasis depends on the cells in the primary tumour - 
not all have the same potential to disseminate - and also on the new host environment. 
Certain organ sites (termed 'metastatic niches') have been realised to be especially 
permissive for metastatic colonisation. This has led to the so-called 'seed and soil' 
hypothesis, which encompasses two findings: Firstly, the primary tumour (the 'seed') 
consists of genetically and phenotypically heterogeneous cancer cell populations, which 
can complement the metastatic capabilities of one another. As different organs require 
unique survival and colonisation strategies, metastasis-triumphant cells are selected for 
specific survival-promoting attributes. Thus, distinct metastases may originate from the 
same primary tumour, yet from different cancer cell populations within the tumour. 
Consequently, metastases at distinct locations can differ biologically greatly from each 
other - one of the major obstacles in cancer treatment. And secondly, tumours also 
harbour host cells (such as fibroblasts or infiltrating leukocytes) that interact with the 
cancer cells and often in conjunction with the microenvironment ('the soil'), accidentally, 
support tumour growth, angiogenesis, and invasion - hence malignancy. This sinister 
cooperation between cancer cells and the host's microenvironment is especially 
significant during cancer cell invasion (Langley and Fidler, 2007). The impact of 
receptive metastatic niches is reflected in the common observation that many neo-
plasms are found to preferentially colonise to certain organ sites (Ben-Baruch, 2008). 
 
3.2 Cutting the Cord - EMT 
 
Cancer cells evolve a variety of strategies in order to break away from the primary 
tumour, invade into adjacent tissue, and resist apoptosis - and dysfunctional integrin 
signalling is involved in all of them.  
Carcinoma cells (malignant tumours of epithelial origin) acquire invasive attributes by co-
opting a regulatory mechanism normally employed during embryonic morphogenesis 
and wound healing: the epithelial-mesenchymal transition (EMT). During EMT, epithelial 
cells acquire a mesenchymal-like morphology by loosing their apical-basolateral polarity, 
disrupting cell-cell contacts, and, as a consequence, gain cell motility. In terms of 
malignant carcinoma cells, EMT induces complete or partial dedifferentiation resulting in 
cancer cells with highly dynamic and adaptive features - one of them being the acquire-
ment of invasive capabilities (Thiery, 2002).  
 
A number of transcription factors, including Slug, Snail, and Twist, orchestrate EMT 
during embryogenesis, and are known to be over-expressed in various tumours 
(Hanahan and Weinberg, 2011). Amongst other functions, these transcription factors 
suppress E-cadherin expression, and hence induce the weakening of adhesive bonds 
between cells. E-cadherin normally forms adherens junctions by mediating stable, 
homophilic interactions at the cell surface and connecting to the cortical actin cyto-
skeleton via - and -catenin. Some carcinoma cells express the neuronal (N-) cadherin 
in response to the loss of epithelial E-cadherin, but this adhesion molecule mediates 
only weak intercellular connections (Thiery, 2002). In addition to its cohesive role, E-
cadherin also functions to represses cell proliferation ('contact-inhibition'). Loss of E-
cadherin induces the translocation of the associated -catenin to the nucleus, where it 
cooperates with transcription factors to regulate gene transcription and enable 
proliferation and survival even in the absence of cell-cell contacts (Brembeck et al., 
2006). 
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The integrity of functional epithelia is further supported by apically localised tight 
junctions, and loss of these structures can also induce EMT. Tight junctions are large 
multi-protein complexes that contain predominantly, but not exclusively, the transmem-
brane proteins occludin and claudins, as well as the cytosolic signalling and scaffolding 
protein zonula occludens 1 (ZO-1), which anchors membrane-integral components to 
the actin cytoskeleton (Reichert et al., 2000). ZO-1 contains multiple protein-interaction 
domains, amongst others an N-terminal triplicate of PDZ- (Post-synaptic density 95; Disc 
large tumour suppressor; Zonula occludens 1) domains. PDZ-domains are superior 
signalling hubs that create functional protein complexes and determine their cellular 
localisation due to their multifaceted binding epitopes: They bind the C-terminus of 
several proteins, homo- or heterodimerise with other PDZ-containing proteins, interact 
with lipids in membranes, or bind to proline-rich internal peptide sequences that exhibit a 
kinked conformation (Nourry et al., 2003). It is thus the PDZ-domains that target cyto-
solic ZO-1 to tight junctions. But also the actin-binding region has been recognised to 
affect ZO-1 location to the F-actin–rich tight junctions, and, interestingly, to likewise 
actin-rich, nascent adhesions at the leading edge of migrating cells (Fanning et al., 
2002). 
 
In conclusion, the first step for dissemination from the primary tumour is commonly the 
weakening of intercellular contacts and the loss of apical-basolateral cell polarity. These 
and other invasive attributes are acquired by altered gene expression in the course of 
EMT. Conversely, at sites of metastatic colonisation, motile carcinoma cells can reverse 
EMT-induced morphology changes through the opposing mesenchymal-epithelial 
transition (MET). MET then results in the recovery of epithelial characteristics, which 
facilitates the integration of solitary cancer cells to establish a solid metastasis (Thiery, 
2002).    
 
3.3 Cancer Invasion as a Result of Usurpation and Adaptation 
 
In practice, many cancer cells are not fully dedifferentiated and instead invade the 
adjacent stroma collectively as cell sheets, preserving intercellular junctions, 
coordinating cytoskeletal activities, and establishing a functional and structural polarity 
that extends across the entire cohort (Friedl and Gilmour, 2009). Collectively migrating 
cells are sterically more constrained than cells invading solitarily. Thus, the locomotion 
of multicellular collectives requires extensive modifications of the surrounding ECM. 
Integrin clustering and activation at the protruding front is known to attract surface-
anchored MMPs and to recruit soluble proteases. 21, for instance, directly binds and 
engages the cytoplasmic protease MMP1, and 1- and 3-integrins recruit MT1-MMP, 
both enzymes degrading collagen-matrices (Friedl and Wolf, 2003).  
However, if ECM proteolysis is inhibited or integrin functions are impaired, instead of 
stopping their movement, cancer cells are able to adjust their mode of migration 
according to the new migratory challenges. Mesenchymal-like cells simply convert to 
amoeboid migrating cells that, independent of integrin engagement, squeeze through 
pre-existing gaps in the stroma. This compensatory process is termed mesenchymal-
amoeboid transition (MAT) and is characterised by high Rac1 activity, while RhoA/ 
ROCK-mediated signalling is diminished (Friedl and Wolf, 2003). Similarly, collectively 
migrating multicellular cohorts are able to individualise and continue invasion as single 
amoeboid migrating cells (collective-amoeboid transition, CAT). It has been shown that 
1-integrins are especially crucial for the maintenance of cell collectives, as blocking 
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21, 31, and 51 resulted in the dissemination of single cells from primary melano-
ma explants (Hegerfeldt et al., 2002).  
In a nutshell, cancer cells are highly adaptive in their migration and invasion patterns 
and simply adjust to given environmental cues. The resulting diversity and flexibility of 
invasive migration modes certainly increases the difficulty to fight metastases.  
 
Moreover, carcinoma cells that have not undergone EMT, and thus retain their epithelial 
attributes, such as squamous cell carcinoma (SCC) cells, are employing another 
strategy to remodel the surrounding matrix and invade: usurpation of accessory stromal 
fibroblasts. These fibroblasts not only release migration-promoting factors, but also 
actively pave the way for the following epithelial sheets by proteolytic ECM degradation 
(Gaggioli et al., 2007; Hegerfeldt et al., 2002). Remarkably, pioneering fibroblast and 
following carcinoma cells differently activate Rac1 and RhoA signalling pathways. While 
the fibroblast at the tip of the heterogeneous collective powers migration by generating 
traction forces through integrin-mediated RhoA activation and actomyosin contraction, 
SCCs need neither RhoA nor integrin engagement but Cdc42 activity to follow the pre-
generated migration tracks.      
But cancer-associated fibroblasts (CAFs) do much more than to just generate invasion 
paths for carcinoma cells. CAFs have been found to release chemokines and growth 
factors, including EGF, HGF, and TGF, and thereby to contribute to the growth and 
survival of solid tumours (Allen and Jones, 2011). A few CAF specimens have been 
reported to secrete angiogenesis-stimulating factors and thus to attract endothelial 
progenitor cells into the solid tumour (Orimo et al., 2005). And CAFs are further involved 
in the generation of an altered ECM. This includes a modified matrix composition: most 
solid tumours possess a unique profile of ECM proteins, which derives from over-
expression of e.g. fibronectin or tenascin-C, as well as from the expression of multiple, 
alternative splice variants, which are tumour-specific. The altered matrix composition is 
thought to provide additional integrin-binding sites, thereby promoting altered signalling 
and thus tumour growth and invasion (Allen and Jones, 2011). In addition to the 
remodelling of ECM patterns, CAFs also impact the mechanical properties of the matrix. 
A rigid surrounding has been shown to be favourable for tumour progression and 
dissemination. Reduction of ECM stiffness can even repress the malignant behaviour of 
breast epithelial cells (Paszek et al., 2005). In order to generate a stiff matrix, some 
CAFs secrete lysyl oxidase, an enzyme that cross-links collagen and elastin fibres. The 
resulting tightened matrix reinforces 1-integrin clustering, enhances focal adhesion 
formation, and downstream signalling, which consequently results in profound and 
robust promotion of tumourigenesis (Levental et al., 2009).  
To date, the origin of CAFs is controversial. They may evolve from normal stromal 
fibroblasts in response to carcinoma cell-induced local stimulation or from cancer cells 
that have undergone EMT. It has even been reported that non-tumour associated 
fibroblasts, isolated from women with breast cancer, differ from those derived from 
women without breast cancer - pointing to an inherent (genetic or epigenetic) host 
predisposition for a pro-tumourigenic microenvironment (Allen and Jones, 2011). It is 
clear, however, that CAF properties differ from those of normal stromal fibroblasts. 
Immortalised but non-transformed prostate epithelial cells have been shown to acquire 
carcinogenic attributes when co-cultured with tumour-associated fibroblasts, but not in 
the presence of normal prostate fibroblasts. Interestingly, CAFs were not able to 
stimulate tumour development in non-immortalised benign prostate epithelium, indicating 
that some prior abnormality is conditional for a carcinogenic response to CAFs (Allen 
and Jones, 2011).  
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In addition to CAFs, also macrophages have been realised to be exploited by cancer 
cells. These so called tumour-associated macrophages (TAMs) are found in most solid 
tumours and, like CAFs, secrete tumour growth-, survival-, and invasion-promoting 
factors. TAMs presumably derive from activation by tumour-secreted inflammatory cyto-
kines (Lewis and Pollard, 2006). Together with other inflammatory cells, TAMs are 
believed to contribute predominantly to the recruitment of endothelial progenitor cells 
and hence to tumour neovascularisation (Li Calzi et al., 2010). 
 
In conclusion, tumour cells are able to evolve a mere infinite number of strategies in 
order to capture and colonise new niches in the body. By adaptation to emerging growth 
and invasion challenges, as well as by exploitation of the host's microenvironment, 
metastasising cancer cells are notoriously hard to kill. 
 
3.4 Invasion Devices: Invadopodia and Podosomes 
 
Whenever malignant cells invade the stroma, they form specialised membrane 
protrusions dedicated for local ECM degradation - invadopodia.  These structures are 
actin-enriched membrane extensions underneath the cell body, often in proximity to the 
nucleus. Invadopodia contain integrins, tyrosine kinases, and most importantly soluble 
and membrane-anchored MMPs (Ayala et al., 2006). Invadopodia formation requires the 
small GTPase Arf6, as loss of Arf6 blocks both, invadopodia formation and carcinoma 
cell invasion, but has no impact on adhesive properties (Hashimoto et al., 2004).  
Podosomes, on the other hand, are dynamic and punctual structures, also rich in F-actin 
and located at the ventral site of the cell body. And like invadopodia, podosomes exhibit 
ECM proteolytic functions, but additionally fulfil adhesive tasks during migration. 
Podosomes resemble focal adhesions owing to their composition of vinculin, talin, and 
-actinin, and additionally contain a number of actin remodelling proteins, such as 
gelsolin, Arp2/3, or N-WASP (Buccione et al., 2004). Podosomes are formed by TAMs in 
response to the colony-stimulating factor 1 (CSF-1), a macrophage growth factor and 
chemoattractant secreted by carcinoma cells (Yamaguchi et al., 2006). Notably, 
carcinoma cells and TAMs have been found to establish a paracrine CSF-1/EGF loop by 
which they mutually promote their joint invasion. Cancer cells secrete CSF-1 and 
express EGF-receptor (EGFR), while TAMs release EGF and expose the CSF-1 
receptor. The subsequent formation of invadopodia and podosomes then synergistically 
promotes mammary tumour invasion (Wyckoff et al., 2004).  
  
3.5 Partners in Crime: Integrin and Growth Factor Receptors 
 
Integrins and growth factor receptors exert a joint control on tumour survival, growth, 
and dissemination. The nature of their cross-talk is complex, and can be both, 
synergistic or mutually inhibitory (Alam et al., 2007).  
Integrins have been shown to trigger receptor tyrosine kinase (RTK) inactivation and 
even degradation. The T-cell protein tyrosine phosphatase TCPTP, for example, is 
recruited to the plasma membrane by the cytoplasmic domain of 1-integrin hetero-
dimers. The hence activated phosphatase then dephosphorylates a number of growth 
factor receptors, including EGFR, PDGFR, and VEGFR2 (Mattila et al., 2010). 
Moreover, integrins can also affect the rate of RTK degradation: Loss of cell attachment 
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resulted in immediate proteasomal degradation of the PDGFR, whereas integrin-
mediated adhesion protected PDGFR from this catabolic fate (Baron and Schwartz, 
2000).  
 
But commonly, integrins and RTKs exert collaborative signalling functions. A prominent 
example for their synergistic action is the activation of the cytoplasmic kinase FAK, 
which serves as an integrative scaffold downstream of pro-migratory signals from both 
receptors. FAK is recruited by clustered integrins to sites of nascent focal complexes, 
where it is positioned close to its target effectors. Migration initiated by growth factor 
stimulation (by EGF and PDGF) requires concomitant association of FAK with RTKs and 
integrins, only then allowing the recruitment and activation of migration-promoting 
effectors such as the Src kinase (Sieg et al., 2000). Another example is the laminin-
binding integrin 64, which has been found to be crucial for the invasive growth of 
carcinoma cells following activation of EGFR or the c-Met receptor for the hepatocyte 
growth factor (HGF). Interestingly, 64 adhesion to laminin was not required, pointing 
to a non-adhesive role of this integrin as a RTK signalling-amplifier (Trusolino et al., 
2001).  
Conversely, 21-integrin has been shown to play a more active and direct role in the 
activation of EGFR at sites of cell-cell contacts, where association of EGFR with 21 
enables the activation of the RTK independent of EGF-stimulation but dependent on 
integrin-ligation (Yu et al., 2000). Generally, integrins have been found to potentiate the 
signalling responses of RTK receptors for insulin, PDGF, EGF, and VEGF (Moro et al., 
2002).   
The possible sinister cross-talk between integrins and growth factor receptors is 
especially evident in recent observations showing that integrin function-blocking agents, 
developed as potential anti-cancer drugs, might at low doses even stimulate tumour 
invasion and angiogenesis. Caswell and co-workers found that blocking of v3-integrin 
by either the soluble ECM protein osteopontin or the v-specific inhibitory peptide 
cilengitide abrogates its 51-antagonising function. Following v3 inhibition, 51 
strongly binds to EGFR and the recycling-promoting RCP adapter protein, which results 
in their concerted return to the plasma membrane. Thus, the consequences of v3 
inhibition are increased recycling of 51, which promotes carcinoma cell invasion in 
3D, as well as rescue of EGFR from proteasomal degradation. Strikingly, EGFR 
signalling has been found to be amplified under these circumstances, leading to a strong 
activation of Akt/PKB, a known pro-invasive kinase (Caswell and Norman, 2008). 
Similarly, cilengitide-mediated blocking of v3-integrin function was found to stimulate 
the recycling of VEGFR2 via the Rab4-mediated short-loop, instead of targeting the pro-
angiogenic growth factor receptor to the degradative pathway. Thus as a consequence, 
tumour growth was supported by cilengitide in vivo owing to enhanced VEGF-stimulated 
angiogenesis (Reynolds et al., 2009). 
 
Taken together, the interactions between integrin and growth factor receptors are 
versatile, highly complex, and in some cases even adaptive. It has been suggested that 
integrins provide the 'cellular context' for the outcome of growth factor signalling - due to 
their cell type-specific expression and functionality, and owing to their ability to recruit 
different subsets of effector proteins in proximity to RTKs, thereby influencing growth 
factor fate and function (Alam et al., 2007).  
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3.6 The Many Faces of c-Met 
 
The hepatocyte growth factor HGF (also termed HGF/SF) and its receptor c-Met have 
been implicated in the progression of many solid tumours to metastatic disease. In fact, 
c-Met was even first identified as an oncogene in a human osteogenic sarcoma cell line 
(Gentile et al., 2008). However, c-Met exerts also pivotal physiological functions during 
embryonic development and organ formation, as well as in adulthood for liver 
regeneration and wound healing. The physiologic roles of c-Met already imply its 
versatile biological functions: Activation of c-Met induces several signalling cascades 
that collectively drive a complex morphogenetic program termed as 'invasive growth'. 
This involves the loss of cell-cell contacts, scattering and gain of motility, induction of 
angiogenesis, escape from apoptosis, and the ability to proliferate and settle in a new 
environment. These c-Met–induced responses, which are required for normal cells 
during embryogenesis, are evidently also attractive attributes to hijack by metastasising 
carcinoma cells. It is thus no surprise that MET is one of the most frequently deregulated 
RTK oncogenes, and that constitutive c-Met activity is associated with poor patient 
prognosis (Knudsen and Vande Woude, 2008).  
 
The HGF ligand is generally secreted by cells of mesenchymal origin, whereas the 
expression of c-Met is restricted to epithelial cells. The mature c-Met receptor is a 
tyrosine kinase, located at the plasma membrane and comprising a disulfide linked /-
heterodimer. The short -subunit is located entirely extracellularly, while the -subunit 
encompasses a large extracellular region (which is, together with the -subunit, involved 
in ligand-binding), a transmembrane domain, and an intracellular segment, which 
contains the juxtamembrane section, the kinase domain and a C-terminal, regulatory 
multifunctional docking site (Birchmeier et al., 2003). HGF-binding induces c-Met 
homodimerisation and trans-phosphorylation of tyrosines within the catalytic domain 
(Y1230, Y1234 and Y1235). Phosphorylation of specific residues in the C-terminal tail, 
Y1349 and Y1356, then creates binding epitopes for a vast number of adapter and 
signalling proteins (Figure 6). Effectors bind c-Met either directly, such as Src or PI3K, or 
indirectly via its key scaffolding protein Gab1, which mediates most signalling events 
downstream of c-Met (Gentile et al., 2008).  
 
Termination of c-Met signalling is achieved by Cbl binding to Y1003 in the juxta-
membrane domain. Cbl is an E3 ubiquitin ligase that initiates c-Met ubiquitination, inter-
nalisation via clathrin-coated vesicles, transit through the early sorting endosome, and 
eventual lysosomal degradation (Kermorgant and Parker, 2005). But notably, some c-
Met–relayed signals even require receptor internalisation. For example, the activation of 
the MAP-kinase ERK1/2 by c-Met occurs only on early endosomes (Figure 6). From 
there, PKC specifically targets active ERK1/2 to focal complexes at the plasma mem-
brane, whereas PKC promotes the transport of c-Met along microtubules to multi-
vesicular bodies (MVBs), from where it is directed to the lysosomes (Kermorgant et al., 
2004). In addition, hepatic cells have been found to regulate c-Met activation not only by 
HGF-binding, but also by cell-cell contacts. Even in the presence of HGF, hepatocytes 
do not proliferate under confluent conditions - a process termed 'contact inhibition'. This 
is due to the c-Met–induced activation of the transmembrane protein tyrosine phos-
phatase LAR, which dephosphorylates c-Met and hence prohibits its mitogenic down-
stream signalling (Machide et al., 2006). 
 

































Figure 6: Versatile c-Met Signalling.  
c-Met and its ligand HGF regulate a wide range of signalling cascades, stimulating cell 
proliferation, survival, angiogenesis, and motility (collectively termed as 'invasive 
growth'). C-Met signalling is vital during embryogenesis and wound healing processes, 
but owing to its versatile responses also exploited in many carcinoma cells. Following 
activation, c-Met is normally rapidly internalised and degraded. However, cancer cells 
have evolved a number of strategies to constitutively activate c-Met signalling (see text 
for details).     
 
 
In order to avoid termination of signalling and to sustain continuous c-Met activity, carci-
noma cells have evolved a number of mechanisms, which can be categorised in either 
1) HGF-mediated receptor activation, 2) c-Met over-expression, or 3) gain-of-function 
mutations (Gentile et al., 2008). The latter mechanism occurs more rarely, and tumours 
harbouring activating point-mutations are commonly characterised by a long latency. 
However, additional amplification of the mutant MET allele is often the second 
carcinogenic event that ultimately leads to tumour development (Graveel et al., 2004). 
Examples of carcinomas with activating point-mutations in the c-Met kinase domain are 
lung, head and neck, and gastric cancer.  
In contrast to gain-of-function mutations, the quantitative up-regulation of c-Met levels is 
the most frequent mechanism of oncogenic c-Met activation, and can be found in a large 
number of human tumours, for example in metastatic colorectal cancer and esophageal 
adenocarcinoma (Zou et al., 2007). Over-expression of the receptor can occur as a 
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result of genomic amplification, mutations in the degradation-promoting juxtamembrane 
domain, or transcriptional mechanisms. Constitutive c-Met activity is then caused by 
increased ligand sensitivity or by HGF-independent receptor oligomerisation and 
reciprocal activation (Gentile et al., 2008).  
Ligand-mediated c-Met activation is also often found in human cancers and is 
associated with increased aggressiveness of the tumours (Stellrecht and Gandhi, 2009). 
Excessive HGF-stimulation by autocrine mechanisms, through simultaneous expression 
of c-Met and HGF, has been detected in many sarcomas and gliomas, but not in 
cancers of epithelial origin (Knudsen and Vande Woude, 2008). Paracrine c-Met 
activation is often characteristic for the frequently occurring host stroma stimulation of 
tumour angiogenesis, growth, and invasion (Bhowmick and Moses, 2005). Various 
cancer types, including prostate, stomach, skin, oral cavity, mammary gland, and colon 
cancer, secrete factors that enhance HGF expression in adjacent fibroblasts. Such 
carcinoma-derived HGF-inducing molecules are interleukin-1 (IL-1), basic fibroblast 
growth factor (bFGF), PDGF, transforming growth factor-, and prostaglandin E2. 
Fibroblast-emitted HGF, in turn, functions as a potent mitogenic, motogenic, and 
morphogenic factor that promotes carcinoma invasion and metastasis (Matsumoto et al., 
2008).  
 
Interestingly, it has recently been appreciated that oncogenic c-Met signalling requires 
vivid trafficking from the plasma membrane to endosomes (Joffre et al., 2011). Tumour-
associated activating mutations in c-Met failed to promote in vivo tumourigenesis and 
metastasis whenever receptor endocytosis was blocked. Thus, the oncogenic potential 
of c-Met arises not only from its sustained activity, but also from its localisation and 
signalling on endosomes. Moreover, mice harbouring different point-mutations in the 
MET gene locus have been found to develop mutant-specific tumours (Graveel et al., 
2004). This formation of characteristic neoplasms arises supposedly from individual, 
tumor-dependent requirements that are enabled by distinctively affected downstream 
signalling of the respective mutant c-Met.   
 
Even though deregulated c-Met signalling supports multiple stages of tumour 
progression, the de novo formation or initiation of cancer by c-Met alone is slow and 
occurs only after a long latency period (Knudsen and Vande Woude, 2008). Instead, 
dysfunctional c-Met signalling is implicated in the progression of various cancers to 
disseminating and invading tumours. As it is just metastasis that is the most fearsome 
aspect of cancer, much effort has been made to develop a variety of therapeutic 
inhibitors against aberrant c-Met signalling - each with the common goal to retain 
malignant tumours 'static', in both growth and spreading, and hence support surgical 
removal of the tumour and allow disease-free survival of the patient (Eder et al., 2009).  
Currently, HGF-neutralising antibodies, c-Met–targeting siRNAs, dominant-negative 
proteins, small molecule c-Met tyrosine kinase inhibitors (such as SU11274), and 
microRNAs that target c-Met mRNA (Tan et al., 2011) are being investigated as possible 
therapeutic tools against sustained c-Met activation (Stellrecht and Gandhi, 2009). 
Owing to the very diverse effects of oncogenic c-Met, it has also become increasingly 
evident that optimised patient selection for clinical trials, together with the development 
of diagnostic biomarkers, are invaluable for the effective therapeutic targeting of 
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AIMS OF THE STUDY 
 
Cancer becomes life-threatening when malignant cells acquire the ability to escape the 
primary tumour and to penetrate and invade the surrounding tissue in order to colonise 
distant sites in the body. The ominous gain of invasive capabilities provides the potential 
to be therapeutically targeted, yet cell migration is also essential during many physio-
logical processes, such as tissue homeostasis and wound healing. For the development 
of cancer-selective drugs in the future, it is thus of great importance to broaden our basic 
understanding of the complex molecular machineries that orchestrate cell migration 
under diverse circumstances and in different cell types. 
Integrin cell surface receptors are engaged in the perception and integration of 
endogenous and environmental cues. The functional importance of integrin trafficking to 
and from the plasma membrane is known for some time, but yet the detailed molecular 
mechanisms remain ambiguous. How are endocytosis and recycling routes coordina-
ted? What targets integrins to the leading edge of a cell? How does integrin trafficking 
contribute to directed movement? How do growth factor receptors account for cancer 
cell migration and invasion? Even more complexity arises, when cell motility is studied in 
a 3D environment. Are the cellular mechanisms underlying cancer cell invasion in vivo 
distinct from the experimental results obtained on tissue culture plates? 
The aim of this study was to explore migratory mechanisms in 2D and 3D in more detail 
and to find new regulatory pathways that might eventually be exploited in targeted 
cancer therapy.  
 
 
Specific aims were: 
 
 To identify new regulatory proteins, which cooperate with Rab21 on the 
control of integrin trafficking and cell migration. 
 
 To elucidate the mechanisms underlying the breakdown of intercellular 
junctions and resultant increased cancer cell motility. 
 
 To investigate signalling pathways that account for the c-Met–induced 







MATERIAL AND METHODS 
 




Method Used in 
PKC Kinase Assay III 
In situ Proximity Ligation Assay III 
Immunohistochemistry III 
Phosphoprotein Extraction III 
ELISA Binding Assay III 
Adhesion, Migration and Invasion Assays I, II, III 
Scratch-Wound Assay I 
3D Cell Culture and Time-Lapse Microscopy II 
Cell Proliferation Assay III 
Rac and Rho Activation Assay I, II, III 
Flow Cytometry (FACS) I, II, III 
Cell Culture I, II, III 
Immunoprecipitation I, II, III 
Western Blot Analysis I, II, III 
Biotinylation-based Trafficking Assay I, II, III 
Antibody-based Trafficking Assay I 
Pull-Down Assay I 
Immunofluorescence Microscopy I, II, III 
Immunoelectron Microscopy I 
Surface Plasmon Resonance Protein Interaction Assay I 
Fluorescence Polarization Protein Interaction Assay I 
Protein Expression and Purification I, III 
GAP Assay I 
Subcellular Density Fractionation I 






The following constructs were generated: 
Used in I: pEGFP-C2-Rab21, pEGFP-C2-p120RasGAP and its kinase-dead mutant 
(R789A) and ∆GAP construct, pGEX-p120RasGAP full length and its GAP-domain 
alone, pGEX-Rab21, pGEX-APPL1  
Used in III: siRNA-resistant variants of pEGFP-N3-α5 and pEGFP-C1-ZO-1; pGFP-N-
ZO-1, pGFP-C-ZO-1, pLNCX-Flag-ZO-1WT, pLNCX-3Flag-ZO-1PDZ1; pGFP-PKCεWT 





Expression vectors for the following constructs were generous gifts: 
Used in I: pEYFP-N1-RFP and pRFP-N1-232 constructs from A.J. Koleske, Yale 
University, New Haven, CT, USA; pGEX-4T1 p120RasGAP from A. Wittinghofer, MPI of 
Molecular Physiology, Düsseldorf, Germany; pET15b-APPL1 from X.C. Zhang, 





Target Sequence (sense) or name Supplier Used in 
ZO-1 AAAACAGTCACTCCAGCATAC Qiagen III 
ZO-1 AAGATATTGTTCGGTCCAATC Qiagen III 
α5-integrin ATCCTTAATGGCTCAGACAT Qiagen III 
PKCε GAUCGAGCUGGCUGUCUUUTT Qiagen III 
PKCε AAAGACAGCCAGCUCGAUCTT Qiagen III 
Scr Allstars negative control Qiagen III 
Scr Scramble control Ambion I 
Rab21 GGCAUCAUUCUUAACAAAGTT Ambion I 
Rab21 GGUCAAGAGAGAUUCCAUGTT Ambion I 
p120RasGAP GGAAGAAGAUCCACAUGAATT Qiagen I 
p120RasGAP GCUCCCAUAUACCAUUAAATT Qiagen I 
Hip1 GGAACUUGCCACAAGCCAATT Qiagen II 
Hip1 GGCUUAGGAUCGACAAGAATT Qiagen II 
RhoA CGGAAUGAUGAGCACACAATT Qiagen II 





TAT-conjugated α5-peptides as well as biotin-conjugated integrin-peptides were custom 
synthesised by GeneCust, EDANS-labelled peptides by GenScript. 
 
Name Sequence  Used in 
TAT- α5 WT PPATSDA III 
TAT-α5 ADA PPATADA III 





α1 cyt WKIGFFKRPLKKKMEKRPLKKKMEK I 
α2 cyt WKLGFFKRKYEKM I 
α2 12AA AALGFFKRKYEKM I 
α2 34AA WKAAFFKRKYEKM I 
α2 56AA WKLGAAKRKYEKM I 








Cell line Origin Used in 
NCI-H460  human non-small cell lung cancer III 
MDA-MB-231 human breast cancer  I, III 
KF28 and KFr13 human ovarian cancer  I 
MEF murine embryonic fibroblasts I, III 
TIFF 
human telomerase immortalised  
foreskin fibroblasts 
I 
T-REx293–GFP-cMet Tet-inducible, human embryonic kidney II 




Antigen Description Used in 
α5-integrin MCA1949 and Mab1999, Chemicon III 
α5-integrin MCA1187, Serotec  III 
α4-integrin Mab16983, Chemicon III 
αV-integrin L230, Alexis Chemicals III 
ZO-1 mouse mAb, Zymed III 
ZO-1 rabbit pAb, Zymed III 
FAK goat pAb, Santa Cruz III 
FLAG mouse mAb, Sigma-Aldrich III 
Vinculin mouse mAb, Sigma-Aldrich III 
PKCε rabbit pAb, Upstate III 
EEA1 rabbit pAb, Upstate I 
Rab11 rabbit pAb, Invitrogen I 
Rab21  mouse mAb, Santa Cruz I 
Rab21  mouse mAb, Abnova I 
β1-integrin  mouse mAb P5D2, Hybridoma Bank I, III 
β1-integrin  mouse mAb P4G11, Hybridoma Bank I 
β1-integrin  mouse mAb AIIB2, Hybridoma Bank I 
β1-integrin  mouse mAb 12G10, Abcam I 
β1-integrin  mouse mAb 9EG7, BD Pharmingen I 
β1-integrin  mouse mAb Mab13, BD Pharmingen I, II 
β1-integrin  mouse mAb Mab2252, Chemicon I, III 
β1-integrin  mouse mAb K20, Beckman coulter I, II 
β4-integrin  mouse mAb Mab2060, Chemicon II 
p120RasGAP rabbit pAb, BD Biosciences I 
p120RasGAP mouse mAb, BD Biosciences I 
p190RhoGAP rabbit pAb, BD Biosciences I 
RhoA mouse mAb, Cell Signalling I, II 
RFP rabbit pAb, MBL I 
GST rabbit pAb, Invitrogen I, III 




Antigen Description Used in 
Biotin goat HRP-linked Ab, Cell Signalling I, II, III 
c-Met goat pAb, R&D Systems II 
phospho-Met Y1234/5 rabbit mAb, Cell Signalling II 
Vimentin mouse mAb, Santa Cruz II 
α-Tubulin  mouse mAb, Santa Cruz I, II, III 
HIP1 rabbit pAb AB9880, Chemicon II 




Reagent Application Supplier Used in 
Glutathione- 
sepharose beads  





Thrombin protease Protein expression  I 
PreScission protease Protein expression  I 
Lipofectamine 2000 Transfections Invitrogen I, II, III 
HiPerfect Transfections Qiagen III 
Collagen I Cell culture dish coating  I 
Fibronectin Cell culture dish coating  III 
Growth factor  
reduced Matrigel 




Calphostin C PKC inhibitor  III 
Y-27632 ROCK inhibitor Sigma II 
CT04 (C3) Rho inhibitor Cytoskeleton II 
SU11274 c-Met kinase inhibitor Calbiochem II 
Tetracycline Protein expression  II 
HGF Activation of c-Met   II 
ATP PKC kinase assay  III 







DAPI Immunofluorescence  I, II, III 
Mowiol Immunofluorescence Calbiochem I, II, III 
Vectashield  
mounting medium  
Immunofluorescence Vector Labs I, II, III 













Sigma I, III 
Streptavidin-















1.  Balanced Integrin Trafficking - A Prerequisite for Controlled Cell 
Migration and Invasion (I, II, III) 
 
The findings of the publications included in this thesis collectively highlight the general 
importance of balanced and targeted integrin trafficking for proper cell migration and 
invasion. It has become evident that not only integrin endocytosis enables cell migration, 
but also their targeted redistribution to the plasma membrane is essential at the advan-
cing cell front, where integrins are engaged again (Powelka et al., 2004). Moreover, cell 
migration is also a balancing act between cell attachment and detachment, as too much 
as well as too little adhesion is not favourable for forward motion (Strachan and Condic, 
2004). 
 
1.1 p120RasGAP Controls Integrin Recycling (I) 
 
In our previous work, we have identified the small GTPase Rab21 as a regulator of 
integrin endocytosis (Pellinen et al., 2006). With the aim of identifying regulatory proteins 
that are implicated in Rab21-driven integrin trafficking, p120RasGAP aroused our 
interest. p120RasGAP (subsequently abbreviated as p120) is a well-known GAP protein 
for Ras, but has also been suggested as a negative regulator for Rab5, a close homo-
logue of Rab21 (Liu and Li, 1998).  
In order to test p120 implication in integrin endo/exocytic transport pathways, we per-
formed a number of biochemical and microscopic trafficking assays. First, we followed 
the itinerary fate of cell surface-labelled 1-integrins in MDA-MB-231 breast cancer cells 
using a biotinylation-based method. While silencing of p120 had no significant effect on 
integrin endocytosis (I, Fig.1A), siRNA-induced loss of p120 readily diminished the 
recycling rate of 1-integrins compared to control-silenced cells (I, Fig.1B). Similarly, 
when labelling surface integrins with an anti-1 antibody and following their endo/ 
exocytic traffic, integrins were equally well internalised in both control and p120-silenced 
cells under serum-free conditions (I, Fig.1C). However, serum-stimulation triggered the 
redistribution of endocytosed integrins back to the plasma membrane only in control 
cells, whereas p120-siRNA transfected cells showed a reduced ability to recycle 
integrins. Third, we confirmed these findings by electron microscopy (EM), where 
integrins at the plasma membrane were labelled with a gold-conjugated antibody. Also 
with this assay, we observed a reduced ability of p120-silenced cells to return integrins 
to the plasma membrane. Instead, labelled 1-integrins accumulated in cytoplasmic 
vesicles (I, Fig.1D).  
 
In line with our previous finding that Rab21 regulates integrin trafficking, we repeated the 
antibody-based trafficking assay with superficially labelled 1-integrins and consecutive 
internalisation and recycling steps, but additionally co-stained for endogenous Rab21. In 
the absence of p120, there was a strong co-localisation of Rab21 and 1-integrins on 
endosomes, both after the internalisation and the recycling step (I, Fig.7A). In contrast, 
control cells showed in both cases only limited overlap between Rab21 and integrins, 
suggesting that integrins did not remain for long in Rab21-positive endosomes. In 




cytoplasmic co-localisation of surface-derived integrins with Rab21 in p120-silenced 
cells (I, Fig.7C). In control cells, 10 nm-gold–labelled integrins were found predominantly 
at the plasma membrane, distant from Rab21 5 nm-gold labels found on vesicular struc-
tures. In order to identify the endosomal compartment, where in the absence of p120 
integrins accumulate with Rab21, we stained p120-silenced cells for different endosomal 
markers. As a result, we found that, in the absence of p120, integrins got trapped in 
EEA1-positive early sorting endosomes, whereas there was only limited overlap with 
Rab11 or RCP, two markers of recycling endosomes (I, Fig.7B).   
 
In summary, these results implicate the requirement of p120 in the recycling of Rab21-
internalised 1-integrins. If p120 is lost, integrins accumulate in early endosomes 
instead of redistributing to the cell surface. 
 
1.2 Integrin Recycling Regulates Cell Migration (I) 
 
As derailed integrin recycling has been correlated with changes in cellular migration 
modes (White et al., 2007; Caswell and Norman, 2008), we aimed to determine the 
impact of p120 on cell motility. We therefore silenced p120 in a number of cell lines, 
tracked their movement with time-lapse microscopy, and then evaluated their migration 
speed and persistence. MDA-MB-231 breast cancer cells, when transfected with p120-
siRNA, migrated with greater speed (I, Fig.S2A) and also closed a wound faster than 
control cells (I, Fig.2A). Importantly, the stimulated migratory behaviour of MDA-MB-231 
cells was specifically attributed to the loss of p120, as re-expression of GFP-tagged wild-
type (WT) p120 reversed the phenotype (I, Fig.2A). Likewise, loss of p120 also 
stimulated the migration of human telomerase-immortalised foreskin fibroblasts (TIFFs) 
and mouse embryonic fibroblasts (MEFs) into a wound (I, Fig.S2B, C). The more rapid 
wound closure was a result of both increased cell migration speed and persistence. The 
observed enhanced cellular motility is likely to be due to aberrant integrin recycling in 
p120-silenced cells, as no alterations regarding 1-integrin cell surface expression or 
activation status could be observed compared to control cells (I, Fig.S3).  
 
Remarkably, the stimulation of cell motility following loss of p120 was only observed in 
cells expressing Rab21. We made this observation using two related ovarian cancer cell 
lines: KF28 and KFr13. In contrast to the parental KF28 cells, KFr13 cells harbour a 
chromosomal deletion in the RAB21 gene locus, thus lacking Rab21 but not 1-integrin, 
Rab5, or p120 (I, Fig.S4A). The absence of Rab21 in KFr13 cells resulted in the failure 
of 1-integrin endocytosis (I, Fig.S4B) and a mere ventral plasma membrane distribution 
of 1-heterodimers (I, Fig.2C). In contrast, parental KF28 cells internalised 1-integrins 
normally and showed a typical distribution of the integrin, both at the cell surface and in 
endosomes in the cytosol. Moreover, silencing of p120 resulted in enhanced persistent 
migration only of KF28 cells, whereas loss of p120 had no impact on KFr13 cell motility 
(I, Fig.2D).   
 
In brief, p120 appears to regulate cell migration by enabling the redistribution of Rab21-
internalised 1-integrins back to the plasma membrane. Derailed integrin recycling, due 





1.3 Directed Migration Requires the Targeted Transport of Integrins and 
ZO-1 to the Leading Cell Edge (III) 
 
Apart from balanced trafficking, integrins also need to be specifically targeted to the 
advancing lamellipodium at the cell front. Furthermore, the generated leading edge 
needs to be maintained and stabilised in order to allow directionally persistent cell 
migration. With the aim to investigate how integrins are delivered to the emerging 
leading edge and how the cell front in turn is stabilised, we used the invasive non-small 
cell lung cancer cell line NCI-H460. 
 
In functional epithelia, integrins mediate cell-matrix contacts on the basolateral side of 
the polarised cell layer. Accordingly, when NCI-H460 cells were resting in a confluent 
monolayer, 51-integrins resided in intercellular contact sites (III, Fig.1A). However, 
following a migratory stimulus by applying a scratch wound to the monolayer, NCI-H460 
cells polarised towards the wound edge. Simultaneously, 51-integrin, but not 21, 
was redistributed to the advancing lamellipodium (III, Fig.1A; Fig.S1A, B). This specific 
recruitment of 51 to the cell front was required for the breakdown of cell-cell contacts, 
the initiation of cell motility, and also for invasion into a 3D fibronectin-matrix, as blocking 
51 function with an antibody or siRNA inhibited all these functions (III, Fig.S2A; Fig. 
1B, C).  
 
The integrity of functional epithelia is further supported by apically localised tight 
junctions, with the signalling and scaffolding protein ZO-1 being one of their major 
components. Since it has been shown that ZO-1 not only localises to tight junctions, but 
also to nascent adhesion sites at the leading edge of migrating cells (Fanning et al., 
2002), we aimed to investigate the localisation of 51-integrin and ZO-1 in NCI-H460 
cells. Indeed, in immotile cells, there was no co-localisation of the two proteins (III, 
Fig.2A, B). Both proteins were found at intercellular junctions, but ZO-1 was restricted to 
the apical site and 51 to the basolateral surface. However, in sub-confluent actively 
migrating cells, this compartmentalisation was lost, and ZO-1 and 51 strongly co-
localised at the advancing lamellae as assessed by IF (III, Fig.2A, B) and a proximity 
ligation assay (PLA; III, Fig.3C, D). Correspondingly, we could co-immunoprecipitate 
51 and ZO-1 only from cell lysates that derived from sub-confluent migrating cells, but 
not from a confluent cell monolayer (III, Fig.3A). The concomitant recruitment of ZO-1 
and 51-integrin to the leading edge was integrin-specific, as we did not detect a ZO-1 
association with 21 (III, Fig.3B). However, we observed 51–ZO-1 co-localisation 
also in MDA-MB-231 breast cancer cells, indicating a cell type-independent mechanism 
(III, Fig. S4A).     
 
In order to understand the role of ZO-1 at the lamellipodium, we analysed the effect of 
ZO-1 loss on the migration of NCI-H460 cells. We found that ZO-1–silencing significantly 
reduced cell migration towards a chemotactic stimulus in a Transwell assay (III, Fig.2C) 
and abolished overall directionally persistent migration (III, Fig.D, E). In line with its role 
in directional cell motility, ZO-1 loss in NCI-H460 cells also resulted in the impaired 
formation of a prominent lamellipodium. Instead, the cells exhibited multiple protrusions 
in several directions compared to control cells that were clearly polarised (III, Fig.2F). 
The deficiency in lamellipodia formation was truly attributed to the loss of ZO-1, as re-
expression of GFP-tagged ZO-1 rescued the defect (III, Fig.2G). Furthermore, the 




Rac1 activity, which is consistent with the observed increased random cell migration (III, 
Fig.S5). However, the loss of ZO-1 and hence the deficient formation of a stable lamelli-
podia had no effect on the recruitment of 51-integrin to the cellular protrusions (III, 
Fig.2F). Silencing of 5-integrin, on the other hand, inhibited the formation of a ZO-1–
positive lamellipodium, and re-expression of GFP-5 reconstituted the defect (III, Fig. 
5B).    
 
Taken together, these data assigned a new role for the tight junction protein ZO-1 in the 
regulation of persistent cell migration. Following a migration-promoting stimulus, 51-
integrin and ZO-1 are specifically targeted to the emerging cell front. ZO-1 is not 
important for 51 redistribution to the leading edge per se, but instead contributes to 
lamellipodium stabilisation and hence directionally persistent cell migration. Direct 
interaction with 51-integrin thereby anchors ZO-1 at the cell front. Interestingly, the 
51–ZO-1 complex formation in motile carcinoma cells found in vitro has also clinical 
relevance in metastasising lung carcinomas in vivo. We analysed 48 lung cancer patient 
samples and found 51–ZO-1 complex formation exclusively in metastatic cancer 
specimens, but not in samples of primary carcinomas that had not spread (III, Fig.S7). 
Thus, the interaction of 51-integrins with ZO-1 at the leading edge of motile cancer 
cells may be a critical switch that allows cancer cell dissemination and invasion. 
 
1.4 Oncogenic c-Met Signalling Enhances Integrin Trafficking and 
Stimulates Cell Invasion in 3D Matrigel (II) 
 
Deregulated activation of the growth factor receptor c-Met has been implicated in the 
progression of a stationary primary tumour to a disseminating and metastasising cancer. 
In order to study the molecular changes that facilitate cancer cell invasion, we utilised an 
epithelial cell model, in which we mimicked oncogenic c-Met signalling caused by either 
c-Met over-expression or excessive HGF-mediated activation.   
 
In order to imitate the quantitative up-regulation of c-Met, we exploited a recently 
developed epithelial cell model (Kermorgant, manuscript) with a tetracycline (Tet)-
inducible expression system for GFP-tagged c-Met. When induced with Tet, these 
human embryonic kidney (HEK) 293 cells (subsequent abbreviated as HEK-Met cells) 
showed sustained activation of c-Met (II, Fig.1A), similarly to tumours that carry an 
amplification of the MET locus (Zou et al., 2007). Interestingly, following Tet-induction, 
these HEK-Met cells underwent a peculiar morphology change on planar surfaces. They 
rounded up (II, Fig.1B) and acquired the ability to survive anchorage-independently, 
which is one of the hallmarks of cancer cells. These c-Met–induced morphological 
changes were accompanied by the loss of 1-integrins from the cell surface owing to an 
enhanced endocytosis rate (II, Fig.1C, D).  
Notably, when embedding HEK-Met cells into a more physiological 3D environment, into 
50 % Matrigel, they eagerly formed multicellular spheric clusters (II, Fig.2A; movie S1). 
However, upon Tet-induction and hence cancer-like c-Met over-expression, HEK-Met 
cells lost the spheroid phenotype instantly and instead converted into a loose assembly 
of individual round cells with amoeboid characteristics (II, Fig.2A; movie S2). 
Nevertheless, the cells remained alive, as even after 72 hours of Tet-induction the cells 
were moving on the spot and proliferating actively (II, movie S3). Moreover, the induction 




inhibitor SU11274, indicating that c-Met catalytic activity provoked this so-called 'onco-
genic rounding' (II, Fig.2A). Importantly, when embedding carcinoma cells originating 
from human gastric tumours with MET amplification into Matrigel, these cells also 
adopted an amoeboid phenotype similar to our Tet-induced HEK-Met cells (II, Fig.2D). 
In order to characterise the nature of the oncogenic morphology changes in more detail, 
we fixed and stained HEK-Met cells in 3D culture in the absence or presence of Tet and 
stained for 1-integrin, actin, and vimentin (II, Fig.2B). Without induction, HEK-Met cells 
formed dense spheric clusters. Interestingly, the IF-protein vimentin was found to be 
expressed only by cells in the outer layer of the spheroid, but not by cells inside the 
structure. After Tet-induction, vimentin was present in all cells of the fragmented 
spheroid. Moreover, in line with the earlier findings on 2D, we noticed also in these 3D 
immuno-stainings that integrins obtained a predominantly cytosolic distribution following 
Tet-induction compared to non-stimulated cells (II, Fig.2C). It has been shown that the 
formation of spheroids in 3D depends on both cell-cell and cell-matrix interactions 
(Casey et al., 2001). Thus, the abrogation of the spheroids by c-Met activation may 
partially be attributed to the loss of integrins from the cell surface. 
 
We also observed c-Met–induced invasive alterations in WT HEK293 cells, which were 
stimulated with exogenous HGF. With these conditions, we mimicked paracrine c-Met 
activation typically found in many CAF-stimulated carcinoma cells (Knudsen and Vande 
Woude, 2008). When embedding WT HEK293 cells into 50 % Matrigel, they formed 
multicellular spheroids just like the HEK-Met cells (II, Fig.3A). However, following 
stimulation with excessive HGF, HEK293 cells did not round up. Instead, the cells 
adopted a mesenchymal phenotype, started to disseminate from the spheric cell cluster 
and progressively invaded as sheet-like cohorts into the matrix (II, Fig.3A; movie S4). In 
the presence of the c-Met kinase inhibitor, HEK293 cells significantly lost their ability to 
disseminate from the spheroid, indicating that the gain of invasive capabilities was owing 
to c-Met signalling (II, Fig.3B). Consistently, in an in vitro invasion assay, HEK293 cells 
migrated through 3D Matrigel towards a gradient of HGF, but remained largely non-
invasive in the absence of HGF-stimulation (II, Fig.3C). In addition, akin to Tet-induced 
HEK-Met cells, also WT HEK293 cells lost 1-integrins from the cell surface following 
stimulation with HGF (II, Fig.3D).  
 
In summary, we have developed an in vitro 3D cell model that allows the investigation of 
morphological and migratory changes induced by sustained c-Met activation. Moreover, 
we found that the effects of oncogenic c-Met signalling vary depending on the receptor-
activating mechanism: While the over-expression of c-Met initiated an amoeboid pheno-
type, HGF-mediated receptor stimulation triggered a mesenchymal morphology with 
distinct cellular invasion characteristics. However, enhanced integrin trafficking, at least 
partially, accounted for the c-Met–induced invasive switch - irrespective of the 
mechanism of c-Met activation.  
 
2. Novel Protein-Protein Interactions and Functions in the Control of 
Cell Migration (I, III) 
 
In the course of our research on integrin traffic and cell migration, we found conceptually 





2.1 An Unexpected Non-GAP Function for p120RasGAP in the 
Regulation of Vesicular Trafficking (I) 
 
When we first found a link between Rab21-controlled endocytosis and p120-stimulated 
recycling of 1-integrins, we were assuming a negative regulatory function of p120 as a 
GAP for Rab21. However, after performing an in vitro GTP-hydrolysis assays with 
recombinant proteins and -[32P]GTP, we found that the purified GAP-domain of p120 
was not able to increase the intrinsic GTP-hydrolysis rate of Rab21 (I, Fig.3A). In 
contrast, p120 GAP-domain did significantly stimulate the GTP-hydrolysis of H-Ras, an 
established substrate of p120.  
Furthermore, we were able to rescue the integrin recycling defect (I, Fig.6A) as well as 
the migration-promoting phenotype (I, Fig.6C, D) in p120-silenced MDA-MB-231 cells by 
the re-expression of both, GFP-tagged WT p120 as well as the catalytically inactive 
R789A mutant form of p120.  
Together, these results unexpectedly indicated to us that p120 GAP-activity is not 
needed for the regulation of neither integrin recycling nor cell migration. 
 
2.2 p120RasGAP Binds Integrins Directly via its GAP-domain and 
Competes with Rab21 (I) 
 
Although the catalytic activity of p120 is not needed, the protein itself is nevertheless 
crucial for appropriate integrin trafficking and cell migration. So how does it function 
then? To address this question, we first performed pull-down experiments with GST-
tagged p120 constructs comprising either the full-length protein, the GAP-deficient 
R789A mutant, or the p120 GAP-domain alone. Interestingly, all three constructs were 
sufficient to pull-down 1-integrins from cell lysates, indicating that the GAP-domain 
itself interacts with the integrin (I, Fig.4B). Using purified GST-tagged p120 protein and 
biotinylated peptides corresponding to the 1-, 2-, or 1-integrin cytodomain in a pull-
down assay (I, Fig.4C) as well as with a surface plasmon resonance-based (BiacoreTM) 
method (I, Fig.S5C), we found that p120 GAP-domain directly binds to the 1- and 2-
subunit of integrins, but not to 1.  
Furthermore, we analysed the interaction between p120 and the -subunit of integrins in 
more detail using a fluorescence polarization (FP)-based assay. And also with this 
method, we detected a direct interaction of the 2-tail peptide with the p120 GAP-
domain, as well as with the full-length WT or mutant p120 protein (I, Fig.4D). Moreover, 
we determined the equilibrium dissociation constants (Kd) with a FP-based titration 
experiment, and found that the GAP-domain alone displayed a similar binding affinity to 
the integrin -tail as the full-length p120 protein (I, Fig.4E). In line with this, we found 
that p120-constructs lacking the GAP-domain but retaining all classical protein-protein 
interaction domains (such as PH-, SH2-, and SH3-domains) failed to rescue the integrin 
recycling defect (I, Fig.6A) as well as the migration-promoting phenotype (I, Fig.6C, D) in 
p120-silenced MDA-MB-231 cells.  
 
Similar to p120, we also demonstrated that Rab21 interacts directly and exclusively with 
the -subunit of 1-integrin heterodimers (I, Fig.4B, C). Interestingly, this interaction was 
not dependent on the nucleotide status of the GTPase, as Rab21 loaded with either 
GDP or the non-hydrolysable GTP-analogue GppNHp had the same binding affinity 




Having found that p120 and Rab21 bind to both, the 1- and the 2- cytoplasmic tails, 
we suspected their integrin-binding epitope to be within the conserved membrane-
proximal sequence that most -subunits have in common: WKLGFFKR (Hynes, 2002). 
Moreover, the arginine R1161 within this sequence has also earlier been shown to be 
important for Rab21 function on integrin traffic (Pellinen et al., 2006). In order to confine 
the integrin binding epitope for p120 and Rab21, we performed a FP-based titration 
experiment using integrin peptides with alanine-mutations within the WKLGFFKR 
sequence (I, Fig.5A). The determination of the corresponding Kd-values revealed that 
alanine substitutions within the residues WK and FF equally strong reduced the binding 
affinities of both, Rab21 and p120 (I, Fig.5B). The KR motif seemed to be important, too, 
but to a lesser extent. In other words, under these in vitro conditions, p120 and Rab21 
possess overlapping binding sites on the -cytoplasmic tail of integrins.      
This finding led us to perform another FP-based experiment: We first determined that 
p120 and Rab21 do not form a ternary complex with the 2-tail peptide (I, Fig.5C). This 
could be excluded because addition of Rab21 to a pre-formed, saturated p120–2 
complex did not yield a further increase of the binding signal. In addition, Rab21 was not 
able to replace p120 from the integrin peptide, as the binding signal did not drop either. 
Conversely, when p120 was added to a complex of Rab21 and 2-peptide, the binding 
signal further increased (I, Fig.5C). Since the final value was identical to the one 
obtained for 2-peptide and p120 alone, and because we also already excluded the 
formation of a ternary complex, we concluded that p120 was able to replace Rab21 from 
the integrin peptide.  
 
The physiological relevance of our competitive hypothesis in cells was supported by the 
findings that p120-constructs, specifically lacking the GAP-domain, were not able to 
rescue neither the integrin recycling deficiency (I, Fig.6A) nor the migration-stimulating 
effect in p120-silenced MDA-MB-231 cells (I, Fig.6C, D). In contrast, the catalytically 
inactive R789A p120 mutant was able to fully reverse the traffic and migration alterations 
induced by the loss of p120 (I, Fig.6).      
 
In conclusion, our data support a model in which Rab21-binding to the membrane-
proximal sequence of the -subunit enables 1-integrin endocytosis and transport to the 
early sorting endosome. There, due to its high cytosolic concentration and its slightly 
higher affinity, p120 is able to replace Rab21 from the integrin tail, thus allowing integrin 
transit through the recycling compartments back to the plasma membrane.  
Balanced integrin traffic is a prerequisite for controlled cellular migration. However, in the 
absence of p120, 1-integrin heterodimers are still endocytosed, yet they cannot leave 
from the early endosome. The consequent derailed integrin trafficking resulted in stimu-
lated cell migration in a number of cell lines. Conversely, if Rab21 is lost, 1-integrins fail 
to be internalised, and hence lack of p120 has no effect on 1-integrin trafficking-depen-
dent cell migration (I, Fig.8).  
 
2.3 A Non-canonical PDZ-Binding Motif in the 5-Integrin Cytodomain 
Mediates the Direct Interaction with ZO-1 (III) 
 
The joint function of 51-integrin and ZO-1 at the leading edge of migrating cells in the 
stabilisation of a prominent lamellipodium, prompted us to analyse the nature of this 




ZO-1 contains three N-terminal PDZ-domains that crucially regulate ZO-1 function and 
location. In order to test whether ZO-1 binds 51 via its PDZ- or other binding domains, 
we used GFP-tagged constructs comprising only the N-terminal or C-terminal region of 
ZO-1 in immunoprecipitations. The specific co-IP of the integrin with solely the N-
terminal region of ZO-1 indicated that the interaction occurs through the PDZ-domains 
(III, Fig.4A). This assumption was affirmed by the finding that expression of the C-
terminal ZO-1 construct, unlike the ZO-1 N-terminus, was not able to support cell 
migration (III, Fig.4C, D). In contrast, a GFP-tagged ZO-1 construct comprising only the 
three PDZ-domains was sufficient to co-localise with 51-integrin at the leading edge 
(III, Fig.4E).  
 
We next sought to determine the binding epitope of the ZO-1 PDZ-domains on the 
integrin. Is this interaction even direct? We addressed these questions with an ELISA 
assay using a GST-tagged construct comprising the three ZO-1 PDZ-domains and a 
peptide containing the seven C-terminal residues of the 5-cytodomain (PPATSDA). We 
narrowed our search of the integrin-binding epitope to only the 5-subunit as we have 
observed earlier that other 1-integrin heterodimers, such as 21, did not co-localise 
with ZO-1 at the leading edge, indicating that it is not the 1-subunit that mediates the 
interaction (III, Fig.3B). Furthermore, we choose only the seven last integrin residues, 
because PDZ-domains classically bind to the C-terminus of interacting proteins (Nourry 
et al., 2003). And indeed, with the ELISA assay we found that the 5-tail peptide was 
able to directly bind to the ZO-1 PDZ-construct (III, Fig.5A).  
It has been shown earlier that 5- and 6-cytoplasmic tails directly bind to the PDZ-
domain of a protein named TIP-2 through their C-terminal SDA-sequence (El Mourabit et 
al., 2002), and that this interaction is abolished by mutating the serine within this 
sequence to alanine (ADA). Accordingly, we repeated the ELISA assay with a mutant 
5-peptide carrying this serine to alanine substitution. But we did not detect any 
decrease in the interaction with the ZO-1 PDZ-construct, indicating that other than the 
canonical residues are important for the interaction (III, Fig.5A).    
Since PDZ binding motifs are highly variable and bind also to internal peptide sequences 
that exhibit a kinked conformation, we decided to mutate the two proline residues within 
the 5-tail peptide, as they potentially display such a kinked conformation. And indeed 
the proline-mutant 5-peptide was no longer able to bind to the ZO-1 PDZ-domains in 
the ELISA assay (III, Fig.5A). When transfecting 5-depleted NCI-H460 cells with a 
GFP-tagged mutant 5-integrin, in which the two prolines had been substituted with 
alanines, the cells localised the mutant integrin to the cell surface and normally adhered 
to fibronectin (III, Fig.S6). However, expression of this mutant did not rescue the 
lamellipodia defect and instead it stimulated the formation of multiple protrusions (III, 
Fig.5B, C). This phenotype was also reflected in the migratory behaviour of 5 proline-
mutant–expressing 5-silenced cells. While control or WT 5-integrin–rescued cells 
migrated predominantly in a directionally persistent manner with a single lamellipodium, 
proline-mutant 5-expressing cells migrated more randomly with multiple protrusions in 
several directions (III, Fig.5D; Fig.S6C; movie S5).   
 
Taken together, our data revealed that the PDZ-domains of ZO-1 directly bind to a non-
canonical peptide sequence at the C-terminus of the integrin 5-subunit that contains 
two crucial proline residues. Mutations within these proline residues abolish the 51–




2.4 PKC Phosphorylation of ZO-1 Regulates the Spatiotemporal 
Complex Formation with 51-Integrin (III) 
 
The next question to answer was about the stimulus that triggers the spatiotemporally 
restricted 51–ZO-1 complex formation at the leading cell edge, but not at intercellular 
contact sites. In order to localise to the advancing lamellipodium, ZO-1 has to be re-
leased from its function in cell-cell contacts. Several PKC isoforms have been implicated 
in the disassembly of tight junctions (Avila-Flores et al., 2001), and ZO-1 phosphoryla-
tion following RTK activation is known to influence its localisation and function (Harhaj 
and Antonetti, 2004). We therefore first tested whether the phosphorylation status of 
integrin or ZO-1 differs between immotile, confluent and actively migrating, sub-confluent 
cells. While 51 was not phosphorylated in either situation (III, Fig.S8A), we found 
more phosphorylated ZO-1 in cell lysates derived from sub-confluent compared to 
confluent cells, indicating that ZO-1 is specifically phosphorylated in migrating cells (III, 
Fig.6A). Furthermore, the PKC inhibitor Calphostin C prevented ZO-1 re-localisation to 
the cell front (III, Fig.S8C, D), pointing to a role of a PKC isoform for ZO-1 phosphoryla-
tion - just which isoform? 
To address this question, we transfected NCI-H460 cells with either dominant-negative 
(DN) or WT PKC and PKC. Both isoforms were expressed by the NCI-H460 cells and 
have been linked to cell migration before (Ivaska et al., 2005). While no morphological 
alterations were observed for the PKC forms, expression of DN PKC readily abolished 
lamellae formation (III, Fig.6B). Similar results were obtained with a PKC-specific 
siRNA (III, Fig.6C). Moreover, the loss of PKC resulted in a preferentially nuclear 
localisation of ZO-1 (III, Fig.6C). To confirm our results, we analysed the localisation of 
ZO-1 and 51 in PKC-null MEFs, which were either un-transfected or reconstituted 
with PKC. In the absence of PKC, 51 and ZO-1 rarely co-localised in membrane 
ruffles, quite contrary to the strong co-localisation observed in PKC reconstituted MEFs 
(III, Fig.6D). In addition, we found more ZO-1 co-precipitating with 51 from PKC-null 
MEFs that had been reconstituted with PKC compared to those that had not (III, 
Fig.7A). In line with this, PKC activation was significantly higher in scratch-wounded 
compared to confluent NCI-H460 cells (III, Fig.6E, F). Interestingly, increased PKC 
activity in motile cells had no effect on the endocytosis rate of 1-integrins (III, Fig.S9). 
However, the translocation of 51 to the cell surface was increased in wounded cells 
(III, Fig.6G). Notably, PKC has previously been implicated in the recycling of 1-
integrins (Ivaska et al., 2002). Thus, PKC might contribute to the 51–ZO-1 complex 
formation by enhancing the delivery of integrins to the cell surface at the leading edge.  
Moreover, we directly implicated PKC in the phosphorylation of ZO-1, as loss of PKC 
in motile cells resulted in a reduced level of phosphorylated ZO-1 (III, Fig.7B). ZO-1 
contains a putative PKC phosphorylation site (RxxS168xR) between the first and second 
PDZ-domain. Therefore, we mutated the crucial serine residue to either alanine (inactive 
mutant) or aspartic acid (phospho-mimetic mutant). As assumed, the S168A mutation 
abolished the translocation of ZO-1 to the advancing lamellipodium in motile cells, while 
having no impact on the ZO-1 location to cell-cell contacts in confluent cells (III, Fig.7C). 
In contrast, the phospho-mimetic S168D mutation in ZO-1 resulted in the induction of 
protrusions even in confluent, immotile cells (III, Fig.7C). Consistent with the require-
ment of PKC for 51–ZO-1 complex formation, expression of the S168A ZO-1 mutant 
failed to bind to 51-integrin in motile cells, whereas the phospho-mimetic S168D 




mutant ZO-1 in PKC-null MEFs retained mutant ZO-1 at intercellular contact sites 
irrespective of PKC re-expression (III, Fig.S10). Conversely, WT ZO-1 localised to 
anterior cell protrusions when PKC was reconstituted and resided in cell-cell contacts 
only in the absence of PKC (III, Fig.S10).  
 
In summary, following migration-promoting stimuli, PKC is activated. Elevated PKC 
activity on the one hand supports the recycling of endocytosed 1-integrins to the cell 
surface and on the other hand enables ZO-1 phosphorylation. Phosphorylated ZO-1 
consequently translocates from cell-cell contacts to the leading edge, where it binds to 
51-integrin. The spatiotemporally controlled 51–ZO-1 complex formation is crucial 
for the maintenance of a pronounced lamellipodium and thereby contributes to 
directionally persistent cell migration. In carcinomas, the 51–ZO-1 complex might 
hence contribute to the transition from a polarised, immotile epithelial cell into an 
invasive carcinoma cell.  
 
3. Sustained c-Met Activation Induces Cancer Cell Invasion in 
Cooperation with RhoA and Hip1 (II) 
 
After having found a feasible cell model that allows the investigation of c-Met–induced 
pro-invasive changes in a 3D environment, we sought to identify the effectors of onco-
genically activated c-Met. For this purpose, we performed an RNAi-based high-
throughput cell spot microarray (Rantala et al., 2011) with the Tet-inducible HEK-Met 
cells. With this technique, we identified a number of siRNAs that prevented the 
oncogenic rounding despite the over-expression of c-Met (II, Fig.4). Among the best hits 
were 14 that have been linked with RhoA signalling, including RhoA itself, and Hip1, 
which we became interested in as it is a known clathrin-adapter protein implicated in 
endocytosis and tumourigenesis (Hyun and Ross, 2004).   
 
3.1  RhoA, a New Key Player Downstream of Oncogenic c-Met 
 
RhoA expression levels are known to correlate with malignancy progression in breast 
and testicular germ-cell tumours (Sahai and Marshall, 2002). Likewise, the activation of 
the Rho-dependent kinase ROCK has been shown to induce tumour cell dissemination 
(Croft et al., 2004). However, to the best of our knowledge, to date RhoA has not been 
shown to function as a transducer for c-Met–stimulated cancer cell invasion. In support 
of our finding, it has recently been discovered that c-Met over-expression correlates with 
the over-expression of RhoA in invasive NSCL carcinomas, yet the molecular mecha-
nisms remain unclear (Gumustekin et al., 2011).  
 
In order to verify our finding that RhoA is crucial for the morphology changes provoked 
by sustained c-Met activity, we used HEK-Met cells and inhibited RhoA signalling either 
directly with the Rho-specific inhibitor C3 or by inhibiting its effector kinase ROCK in the 
absence or presence of Tet. As a result, we confirmed that the inhibition of RhoA and 
ROCK prevented the c-Met–induced oncogenic rounding on 2D (II, Fig.5A). In addition, 
RhoA was significantly activated following Tet-induction as assessed by a biochemical 
Rho-activation assay (II, Fig.5B). Moreover, the disruption of spheroids in 3D Matrigel by 




activity (II, Fig.5C). Consistently, HEK-Met cells that were depleted of RhoA due to 
siRNA-silencing failed to respond to Tet-induction and maintained their spheric pheno-
type in 3D Matrigel (II, Fig.5D). Notably, when expressing a constitutively active RhoA 
mutant (RhoA-QL) in HEK-Met cells, they failed to form multicellular spheroids in 
Matrigel, whereas the expression of dominant negative RhoA (RhoA-DN) had no effect 
on the spontaneous formation of spheric cell clusters (II, Fig.5E). Together, our data 
supported the observation that oncogenic c-Met over-expression causes the induction of 
an amoeboid phenotype, which is strongly RhoA/ROCK-dependent (Gadea et al., 2008; 
Friedl et al., 2001).  
 
Interestingly, impeding RhoA signalling by the use of a ROCK inhibitor also prevented 
the HGF-stimulated mesenchymal-type invasion of WT HEK293 cells into Matrigel (II, 
Fig.5F). In brief, our results thus point to a key role of RhoA as an effector of oncogenic 
c-Met. RhoA activation is needed for both, morphological changes and stimulated cell 
invasion induced by sustained c-Met activity. 
 
3.2 Hip1 Mediates c-Met–Stimulated Integrin Endocytosis 
 
We then sought to determine the role of Hip1 for the c-Met–mediated invasive switch in 
cancer cells. As Hip1 is important for clathrin-mediated endocytosis, we first checked the 
effect of Hip1-silencing on the cell surface level of 1-integrins. In HEK-Met cells, the 
loss of Hip1 prevented the clearance of integrins from the plasma membrane following 
Tet-induction (II, Fig.6A) and likewise impeded the Tet-stimulated endocytosis rate of 
integrins (II, Fig.6C). Consistently, WT HEK293 cells that had been silenced for Hip1 
failed to reduce integrin surface levels upon HGF-stimulation (II, Fig.6B).  
 
In the 3D environment, Hip1-silenced WT HEK293 cells normally assembled into 
spheroids, but stimulation with HGF did no longer induce the collective dissemination of 
cells from the spheric cluster (II, Fig.6D). We thus speculated that Hip1 critically 
regulates integrin-dependent cell migration downstream of activated c-Met. In order to 
test this hypothesis, we stimulated HEK293 cells with exogenous HGF and followed their 
invasion into Matrigel in the presence or absence of the 1-integrin function-blocking 
antibody Mab13 (II, Fig.6F). In fact, also the function-blocking antibody prevented the 
dissemination of WT HEK293 cells from the spheroid, just as observed for Hip1-depleted 
cells. Together with the finding that also the broad-spectrum MMP inhibitor III prevented 
the mesenchymal-type invasion of HGF-stimulated HEK293 cells (II, Fig.6F), our results 
support the observation that ligand-mediated c-Met stimulation induces an integrin- and 
MMP-dependent mesenchymal invasion mode. C-Met–recruited Hip1 thereby regulates 
the surface availability of 1-integrins and thus contributes to the stimulated invasive 
behaviour of the cells. 
 
In contrast to the HGF-induced mesenchymal phenotype, when embedding Hip1-
silenced HEK-Met cells into Matrigel, c-Met over-expression by Tet-induction still resul-
ted in the rapid fragmentation of spheroids into individual round cells (II, Fig.6G). This 
could be prevented by the concomitant presence of the c-Met kinase inhibitor or the 
ROCK inhibitor (II, Fig.6G). Likewise, neither Mab13 nor MMP inhibitor III did prevent the 
Tet-induced amoeboid-type morphology changes (II, Fig.S3). These findings are consis-





Taken together, our results assign a new role for Hip1 in the endocytosis of 1-integrins 
following cancer-like sustained c-Met activation (irrespective of the mechanism of 
activation). Hip1 crucially regulated the integrin-dependent mesenchymal migration of 
HGF-stimulated HEK293 cells, but was dispensable for the amoeboid phenotype 
















Following migratory impulses, integrin trafficking is often altered. Conversely, derailment 
of integrin traffic results in distorted cell migration. In the publications included in this 
thesis, we have found new mechanisms that haven broadened our understanding about 
these two interdependent cellular processes. However, still not all questions are 
answered, and more riddles are yet to be solved.  
 
1. Differential Roles of p120RasGAP during Cell Migration 
 
In the first publication included in this thesis we have identified a novel function for p120 
in the regulation of cell migration, which is independent of its catalytic activity but 
nevertheless dependent on its GAP-domain (Figure 7). Moreover, the migration-
repressing function of p120 described by us does not involve the established interaction 




Figure 7: Joint Regulation of 1-
Integrin Trafficking by Rab21 and 
p120. 
Rab21 mediates the endocytosis of 
1-integrins and their transport to 
the early endosome (EE). P120 then 
replaces Rab21 on the integrin -
cytodomain and thereby permits the 
recycling of integrins back to the 
plasma membrane (PM).   
 
1.1  The Promiscuous Role of p120RasGAP during Cell Migration 
 
P120 is a multifunctional protein that exerts various cellular functions. The GAP protein 
has first been identified as a negative regulator of Ras signalling downstream of 
numerous growth factor receptors (Marshall et al., 1989). However, depending on the 
microenvironment, p120 can function up- or downstream of Ras and also Ras-indepen-
dently. P120 exerts survival, pro- or anti-proliferative functions, and also critically regu-
lates cell migration (Pamonsinlapatham et al., 2009).  
 
We found that down-regulation of p120 by RNAi stimulated the directional motility of a 
number of cell types. In cells that already migrated intrinsically persistent, for example in 
MDA-MB-231 cells and in MEFs, the lack of p120 increased only the speed of migration 
(I, Fig.2A; Fig.S2C). In contrast, in cells that displayed more random motility (e.g. KF28 
cells or TIFFs), silencing p120 resulted in the strong induction of directionally persistent 
motility (I, Fig.2D; Fig.S2B). Moreover, the migration-promoting effect was dependent on 
the knockdown efficiency of the respective p120-siRNA. As seen in figure S2C (I) for the 











also the stimulating effect on the migration of cells transfected with this siRNA was more 
modest compared to siRNA 3. 
 
However, in contrast to our findings, earlier work by Kulkarni and colleagues reported 
that MEFs, isolated from p120 null mice, failed to polarise and migrate towards a wound, 
yet stimulation with PDGF rescued the migration defect (Kulkarni et al., 2000). They 
therefore hypothesised that p120 critically regulates cell migration in a Ras-dependent 
manner. But PDGFR stimulation has been found to promote cell migration also Ras-
independently by activating Rac1 at the leading cell edge and via PDGFR endocytosis 
(Kawada et al., 2009). More recently, King and co-workers found also 1-integrins to be 
important for the chemotactic migration of fibroblasts towards PDGF. Following stimula-
tion, PDGFR prompted the activation of 1-integrins at the leading edge. Active 1-
integrin, in turn, stabilised and activated Cdc42 and N-WASP, two proteins that permit 
directed migration of polarised cells (King et al., 2011). In other words, the PDGF-
stimulated rescue of the migration-deficiency of p120 null MEFs observed by Kulkarni et 
al. may be attributed to other, Ras-independent mechanisms.  
Nevertheless, the p120 knockout MEFs used for their study did not migrate much under 
serum-free conditions, which is contradictory to the migration-promoting effect we 
observed following siRNA-mediated loss of p120. This discrepancy may be attributed to 
the different silencing efficiencies obtained by either siRNA-transfection (about 80-90% 
reduction) or complete loss of the protein in cells derived from knockout animals. Owing 
to the early lack of p120, these MEFs may have evolved other, p120-independent 
strategies to compensate for the loss. In line with this hypothesis are our observations in 
the ovarian cancer cell line KF28 and its Rab21-deficient variant KFr13 (I, Fig.2C, D). 
KFr13 cells lack Rab21 due to a chromosomal deletion. Despite their inability to traffic 
1-integrins, KFr13 cells were able to migrate actively, in striking contrast to MDA-MB-
231 cells that have been silenced for Rab21 only temporary using shRNA, and whose 
migration was strongly impaired (Pellinen et al., 2006). Thus, KFr13 cells have presum-
ably acquired the capability to use for their migration other integrins, whose trafficking is 
not dependent on Rab21 (and thus p120). Similar compensatory mechanisms may have 
evolved in p120 null MEFs.  
It would be interesting to see whether the re-expression of Rab21 in KFr13 cells would 
make their migration susceptible for p120 intervention. Similarly, would loss of p120 still 
affect the migration of KF28 cells, if they were silenced for Rab21? Presumably, those 
cells would not migrate (as seen for Rab21-silenced MDA-MB-231 cells) and would not 
respond to the knockdown of p120, because they are not able to traffic 1-integrins and 
also have not had enough time to evolve other migratory mechanisms. Alternatively, 
different cell types may simply have different potential to compensate for p120 deficits.  
Another indication that p120 regulates cell migration independent of Ras inactivation is 
the work by Pamonsinlapatham and colleagues. They showed that p120 knockdown in 
cells expressing constitutively active, oncogenic K-RasV12 resulted in increased cell 
migration (Pamonsinlapatham et al., 2008). Of the cells that we have used, also MDA-
MB-231 cells harbour an oncogenic Ras mutation, but none of the other cell lines. 
However, the finding of Pamonsinlapatham et al. already points to a migration-regulating 
function for p120 that does not rely on Ras inactivation.  
 
In the study of Kulkarni et al., also the re-expression of p120 rescued the migration 
defect of p120 null MEFs in a concentration-dependent manner (Kulkarni et al., 2000). 
This was accompanied by the complex formation between p120 and p190RhoGAP (sub-




stimulation, p120 and p190 interact, and that this interaction critically regulates actin 
cytoskeleton reorganisation (Chang et al., 1995). Later, Hu and Settleman found that 
receptor tyrosine kinase activation leads to Src-mediated phosphorylation of two tyrosine 
residues in the p190 protein (Y1105 and Y1087), which then serve as dual binding 
epitopes for the two SH2-domains of p120 (Hu and Settleman, 1997). The importance of 
the p120–p190 complex for cell spreading and polarisation has been shown by Bradley 
et al. (2006). Moreover, they reported that integrin-mediated adhesion results in the 
activation of the non-receptor tyrosine kinase family Abl, which includes Abl and Arg. 
Like Src, also active Arg kinase phosphorylates p190 and thus promotes the complex 
formation with p120. Bradley and colleagues showed that p120 association with p190 
was critical for the redistribution of the complex to the cell periphery, where p190 
transiently inactivates RhoA (Bradley et al., 2006). Expression of a RFP-tagged p120 
fragment comprising its SH2- and SH3-domains (RFP-232) impeded the p120–p190 
interaction and thus prevented p190 re-localisation to and activity at the plasma 
membrane. Notably, the findings of this study were obtained during initial cell attachment 
and spreading on fibronectin.  
We have been using the same dominant-negative RFP-232 construct in order to 
elucidate a possible contribution of the p120–p190 complex for cellular migration. 
However, we did not observe any significant differences in the motility of either RFP or 
RFP-232 expressing cells (I, Fig.S5B). In addition, we also did not detect changes in the 
cellular level of active RhoA following p120 knockdown (I, Fig.S5A), indicating that the 
p120–p190 interaction and subsequent RhoA inhibition do not regulate cell migration per 
se. Instead, this complex appears to be important for efficient cell spreading, the 
formation of initial cellular protrusions, and the sampling of the environment (Arthur et 
al., 2002). This hypothesis is supported by the work of Tomar and co-workers, who 
reported that integrin-activated FAK targets the p120–p190 complex to the leading cell 
protrusions, where it maintains cell polarity (Tomar et al., 2009). Indeed, RhoA activity 
has been found to undergo a dynamic tri-step regulation: Integrin-signalling initially 
promotes RhoA inactivation, which locally abrogates RhoA-mediated contractility and 
prevents the maturation of nascent adhesion complexes. This allows the formation of 
dynamic cellular protrusions that probe the environment. Subsequently, RhoA activity is 
elevated again, triggering stress fibre formation and focal adhesion maturation, which 
leads to the establishment of a prominent protrusion in the direction of migration. Finally, 
RhoA activity returns to a basal level, which is important for the maintenance of cell 
polarity (Arthur and Burridge, 2001). Interestingly, it has been shown that these patterns 
of RhoA activity at membrane protrusions depend on extracellular cues and the 
migration-initiating stimulus. In other words, the spatiotemporal regulation of RhoA 
activity in growth factor-stimulated cells is not the same as in randomly migrating cells or 
in cells that move towards an induced wound (Pertz et al., 2006).     
 
In conclusion, these findings, in conjunction with our results, allocate a possible dual 
function to p120 during the regulation of cell migration: First, p120 is necessary for the 
supply of p190 to the plasma membrane, where RhoA is locally and transiently 
inactivated. Thus, in complex with p190, p120 enables cell spreading on extracellular 
matrices and the establishment of a polarised cell. Second, p120 is required on early 
endosomes in the cytosol, where it allows the recycling of 1-integrins during cell 
migration. It may be possible that these two cooperative p120 functions occur 
consecutively (after p190 dephosphorylation, p120 may be released and return to the 




Alternatively, it has been suggested that EGFR, p120, Ras, and Annexin A6 jointly 
internalise through clathrin-coated vesicles (Vila de Muga et al., 2009). It is thus possible 
that p120 is targeted to early endosomes via EGFR co-endocytosis. However, it is 
conceivable that the requirement for p120 to facilitate cell spreading at the plasma 
membrane is transient, and that after the cell has spread and orientated towards the 
migratory stimulus, p120 predominantly regulates integrin trafficking. This might explain 
why we did not observe any basal changes in RhoA activity in p120-silenced cells.  
 
1.2 Impaired Integrin Recycling: Pro- or Anti-Migratory? 
 
In the first paper we also studied the role of integrin trafficking during cell migration. We 
found that derailed recycling of integrins, owing to the loss of p120, has a stimulatory 
effect on the migration of a number of cell types.  
It has been known for some time that integrin trafficking, and recycling in particular, 
critically regulates cell migration (Jones et al., 2006; Petrie et al., 2009). However, 
impaired recycling has often been linked with diminished cell motility (Ivaska et al., 2002; 
Powelka et al., 2004; Mammoto et al., 1999). Other studies have shown that it is not 
mere inhibition of general recycling pathways that alters cellular motility, but rather the 
mutual influence of integrin-specific trafficking routes that contributes to the respective 
migration mode (White et al., 2007; Caswell and Norman, 2008). Moreover, the cellular 
context has been demonstrated to determine whether increased integrin recycling 
supports or compromises cell migration. For example, in breast and ovarian cancer 
cells, the increased expression of Rab25 has been found to promote 1-integrin recyc-
ling and consequently the invasion of these tumour cells into a 3D matrix (Caswell et al., 
2007). By contrast, in colon cancer, the loss of Rab25 has been correlated with poorer 
patient survival (Goldenring and Nam, 2011). Rab25-deficient mice showed elevated 
levels of intracellular 1-integrin in the cells of the villus, which was associated with 
increased susceptibility to colon carcinogenesis. It has thus been proposed that both 
over-expression as well as loss of Rab25 result in imbalances in the surface delivery of 
integrins or associated proteins (e.g. EGFR), and hence contribute to impaired cell 
migration (Goldenring and Nam, 2011).   
 
We have found that p120 operates on early sorting endosomes (I, Fig.7B), where it 
substitutes Rab21 from the integrin -subunit. This replacement is necessary to allow 
the integrin to proceed to the PNRC and via recycling endosomes back to plasma mem-
brane. It remains a topic for further investigation how p120 itself is released from the 
integrin cytodomain and where this release occurs. Does p120 withdrawal occur already 
on early endosomes? Does RCP, known to be critical for the recycling of 1-integrins, 
pursue the redistribution of integrins from the PNRC onwards - maybe even by releasing 
p120? Or does p120 accompany the itinerary integrin all the way back to the plasma 
membrane? The latter hypothesis may be subverted by the only limited co-localisation 
we observed between integrins and p120 under steady-state conditions (I, Fig.5D). This 
implies that the encounter between p120 and integrins is rather brief, and that p120 is 
presumably released on-site.   
 
As the loss of p120 resulted in strong accumulation of integrins in Rab21-positive 
vesicles (I, Fig.7A, C), we hypothesise that p120 functions as a universal regulator for 
the recycling of the majority of 1-integrins. This hypothesis is supported by the integrin-




-subunits (I, Fig.5B). Even though we determined the p120-binding epitope only on the 
2-cytodomain in more detail, it is conceivable that the same residues of other integrins 
also mediate the interaction with p120. Thus, p120 may indeed have a role as a master-
regulator for integrin recycling. Upon the loss of p120, this extensive recycling mecha-
nism is impaired, but other recycling pathways may then account for the targeted 
delivery of integrins to the plasma membrane. For example, it is possible that in the 
absence of p120, integrins bypass the commonly used long recycling route and, instead, 
exit the early endosome and return to the plasma membrane via the short, Rab4- and 
PKD1-dependent recycling loop. This may be feasible only for certain integrins, but not 
the majority of adhesion receptors. Integrin v3, for example, is able to rapidly recycle 
through the short-loop pathway (Woods et al., 2004). Moreover, this integrin has been 
associated with increased directional persistent migration (Danen et al., 2005).  
Alternatively, instead of circumventing the long recycling route, it is also possible that 
following p120 loss, other collateral recycling pathways come to the fore, which were 
otherwise masked by the potent effect of p120. The hence reduced, but possibly more 
targeted recycling of integrins would allow for the formation of a pronounced protrusion 
and thus support directed migration. In order to confirm that neither the Ras-inactivating 
catalytic activity of p120 nor its N-terminal classical protein-protein interaction domains 
account for the regulation of integrin recycling and cell migration, one could express the 
p120 GAP-domain alone and test whether it can rescue the defects in p120-silenced 
cells.  
 
In general, a stringent balance between integrin internalisation and recycling seems to 
be of importance during cell migration. Moreover, the consequences of impaired traf-
ficking have been shown to not only depend on the cell type, but also to a great extent 
on the microenvironment. Strachan and Condic (2004) demonstrated that cells preferen-
tially recycled those integrins, which were mediating their motility. Moreover, they 
proposed that efficient migration not only relies on substrate composition, but also on the 
ratio of integrin cell surface level to ligand availability. The dependency of efficient cell 
motility on integrin recycling was more pronounced in cells cultured on high ligand 
concentrations. By contrast, in the event of low ligand concentrations, the block of 
recycling had less impact on the migration speed and was instead more dependent on 
integrin activation/inactivation (Strachan and Condic, 2004). Therefore, when studying 
the impact of integrin trafficking on the motility of cells, it seems important to bear in 
mind that substrate composition and density, as well as cell type and integrin hetero-
dimer characteristics influence the significance of individual trafficking routes. 
 
1.3 How Do Rab21 and p120RasGAP Cooperate? 
 
The mechanism by which p120 elicits 1-integrin progression through the endosomal 
trafficking machinery implies the replacement of bound Rab21 from the integrin -
cytodomain on early endosomes. Both proteins bind integrin heterodimers on membrane 
proximal residues, which are conserved in most -subunits (I, Fig.5B). However, the 
binding affinities towards the integrin differ: In vitro, p120 possess a slightly higher 
affinity than Rab21, which might in vivo, due to its elevated concentration in the cytosol, 
account for the competitive binding ability of p120 to the integrin (I, Fig.5). This 
conceptual new mechanism arises many interesting questions for further investigation.  
First, can p120 also replace other Rab proteins, possibly Rab5, from integrins? If p120 




novel, general mechanism how early endosomal Rab proteins are released and the 
cargo is handed on. However, to date it has not yet been shown that Rab5 even binds 
directly to integrins. Thus, the competitive mechanism demonstrated by us may be 
unique for the Rab21-driven endocytosis route. It would be interesting, however, to test 
whether recycling Rab GTPases (such as Rab7, Rab11, or Rab25) are in turn able to 
(directly or indirectly) replace p120 from the integrin receptor. Rab25 has been shown to 
bind to the 1-subunit (Caswell et al., 2007), but it could still be possible that integrin-
bound p120 would be released due to conformational changes induced by the Rab25-
binding or due to steric hindrance.  
 
Another question to address is what happens to the integrin cargo when p120 is bound? 
Does the interaction influence its downstream signalling or activation state? And 
conversely, does integrin-binding influence the catalytic activity of p120? The latter is 
feasible to imagine, as p120 interacts with the integrin via its GAP-domain. Further 
analysis will reveal whether p120 GAP activity is elevated or decreased. Interestingly, 
the PH-domain of p120 has been proposed to bind to the GAP-domain and thereby to 
competitively prevent Ras-binding and inactivation (Drugan et al., 2000). May the p120–
integrin binding therefore prevent Ras inactivation as well, or may the interaction even 
release inhibitory contacts and stimulate Ras GTP-hydrolysis? Moreover, it will be 
exciting to test in a FP-based competition assay, whether Ras-binding to p120 
influences its interaction with the integrin -cytodomain and hence its competition with 
Rab21. Furthermore, since it is the GAP-domain of p120 that binds to the integrin -
subunit, the classical N-terminally located protein-protein interaction domains may be 
accessible for binding of other proteins. For example, RCP, a Rab11 adapter protein, 
has been found to link EGFR to 51-integrins and to regulate their joint recycling from 
the PNRC to the plasma membrane (Caswell et al., 2008). What if p120 would be able 
to concomitantly bind integrins and activated RTKs (or other cargo proteins) and thereby 
prevent their sorting to lysosomal degradation and instead retarget them to the recycling 
pathway?  
 
Finally, the regulatory proteins that control Rab21 activity still remain to be determined. 
What are the GEFs and GAPs that regulate Rab21-dependent integrin trafficking and 
cell migration? We found that Rab21 binds integrins in an unexpected nucleotide-
independent manner (I, Fig.3D). However, previous work indicated that Rab21 function 
on integrin trafficking still depends on its nucleotide-bound conformation (Pellinen et al., 
2006). When expressing a GDP-locked Rab21 mutant, integrins failed to internalise. 
Conversely, when expressing a constitutively active GTP-mutant, integrins accumulated 
inside the cell. Therefore, GEF and GAP proteins are certainly required to regulate 
Rab21 function. However, Rab GTPases are known to recruit a number of effector 
proteins that are then responsible for vesicle budding and fusion (Stenmark, 2009). The 
competitive replacement by p120 might hence not be needed for the transport of Rab21 
vesicles, but rather to release the early endosomal Rab and to allow late endosomal 
Rab proteins to take over.  
 
In summary, we found a new function for p120 in the regulation of integrin recycling and 
cell migration. On early sorting endosomes, p120 binds to the -subunit of integrins via 
its GAP-domain and thereby replaces the bound endocytic protein Rab21. This com-
petitive mechanism allows for the transfer of the integrin cargo through the recycling 
compartment back to the plasma membrane. P120 has hence a critical role in the 




2. Novel Regulators of c-Met–Induced Cancer Cell Invasion 
 
We established an in vitro 3D cell model for the investigation of oncogenic c-Met 
activation in a more physiological surrounding than the commonly used monolayer cell 
culture. We therefore embedded epithelial HEK293 cells in 50 % Matrigel, which is a 
reconstituted basement membrane matrix, especially rich in collagens, laminin, fibro-
nectin, and proteoglycans (Shaw et al., 2004), and investigated the cellular behaviour 
following oncogenic c-Met activation by either HGF-stimulation or c-Met over-expres-
sion. With this cell model, we identified new regulatory mechanisms implicated in c-Met–
induced cancer progression (Figure 8). HGF-mediated stimulation of c-Met was found to 
induce collective cell invasion with a mesenchymal phenotype. These cells relied on 
integrin engagement and proteolytic ECM remodelling. In contrast, c-Met over-expres-





















Figure 8: c-Met Effects on Cancer Cell Invasion.  
Oncogenic c-Met signalling triggers the invasion of numerous tumour cells. However, the 
c-Met–promoted migration strategy depends on the activating stimulus: HGF-mediated 
receptor activation results in the collective invasion of cells with mesenchymal characteris-
tics. In contrast, c-Met over-expression contributes to an amoeboid phenotype.  
 
 
2.1  A 3D Cell Model to Study Oncogenic c-Met Signalling 
 
Unexpectedly, the cellular responses to sustained c-Met activity differed depending on 
the mechanism of receptor activation (Figure 8).  
Exogenous HGF-stimulation of WT HEK293 cells induced the dissemination of these 
cells from the spheric cell cluster and their collective invasion into the surrounding 
matrix, while retaining intercellular contacts. HGF/c-Met signalling has been shown to 
activate matrix-degrading MMPs during the mobilisation of haematopoietic cells (Tesio 
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HEK293 cells is dependent on the proteolytic activity of MMPs, while the Tet-induced 
amoeboid phenotype is not. With additional experiments, we aim to test whether MMPs 
are indeed distinctively activated or expressed following c-Met activation by either 
ligand-stimulation or receptor over-expression.  
 
In striking contrast to the HGF-triggerd mesenchymal phenotype, the Tet-induced over-
expression of c-Met caused an amoeboid cell morphology, which resulted in the disrup-
tion of the spheroids into loose assemblies of individual cells with only weak intercellular 
junctions. However, no apparent induction of amoeboid-type cell invasion was observed, 
as the cells stayed on the spot and moved only marginally (II, movie S3). But as the 
amoeboid invasion mode does not rely on proteolytic ECM remodelling, it depends to a 
great extent on the architecture of the matrix (Friedl and Wolf, 2010). Matrigel consti-
tutes a stiffer and more sterically constrained matrix than, for instance, a 3D collagen 
environment. Moreover, the average pore size in 50 % Matrigel is about 2 µm and thus 
much smaller than the cellular dimensions (Zaman et al., 2006). Therefore, over-
expression of c-Met may induce the switch towards amoeboid invasion, yet under the 
given experimental conditions, the cells were unable to move forward due to steric 
hindrance. It is therefore the next step to analyse the motility of Tet-induced HEK-Met 
cells in lower Matrigel concentrations as well as in a collagen environment. Moreover, it 
would be interesting to co-culture HEK-Met cells with MMP-expressing fibroblasts in 50 
% Matrigel, and to see whether the ECM-remodelling ability of the fibroblasts would then 
enable the HEK-Met cells to migrate within Matrigel in a c-Met–dependent manner.  
 
We also found vimentin expression to be up-regulated following c-Met over-expression. 
Vimentin is an IF-protein that is commonly restricted to cells of mesenchymal origin, but 
has been found to be important for cancer cell migration (Vuoriluoto et al., 2011) and to 
be up-regulated in metastatic carcinoma cells (Mendez et al., 2010). Therefore, vimentin 
has become an established marker for cancer cells undergoing EMT, and its expression 
correlates with tumour progression (Ivaska, 2011). It has recently been reported that 
Matrigel is able to induce vimentin expression (Dal Vechio et al., 2011), and thus it 
remains a topic for further investigation, whether the specific vimentin pattern in 
spheroids seen by us is due to the Matrigel environment or not. However, vimentin has 
been shown to be sufficient to provoke cell motility and cell type-depending morpho-
logical changes (Mendez et al., 2010). The observed c-Met–stimulated expression of 
vimentin may thus contribute to the suggested amoeboid invasion mode.   
Interestingly, it has been reported that also the MT-destabilising protein stathmin is over-
expressed in metastatic sarcomas (Belletti et al., 2008). If stathmin was protected from 
inactivation by ECM-contact, the cells obtained a round morphology and gained invasive 
potential by adopting the amoeboid migration mode. In relation to this finding, we 
speculate that elevated c-Met levels may either directly increase MT-dynamics or 
indirectly support stathmin activity by initiating weaker cell-matrix interactions. Stable 
MTs can be determined by staining for post-translational modifications, such as acetyla-
tion (Belletti et al., 2008). We therefore aim to examine the level of acetylated/stabilised 
MTs and stathmin in HEK-Met cells with and without Tet-induction.  
 
The clear differences in the cellular responses following either c-Met over-expression or 
HGF-stimulation raise the question for the underlying mechanism. We studied oncogenic 
c-Met signalling using the same cellular background and the same 3D microenviron-
ment, thus the two cell models differed only in the mechanism of c-Met activation. 




migration characteristics. These different invasion modes may result from differences in 
the duration or magnitude of signal strength. Tet-induced over-expression of c-Met might 
possibly result in a longer or more potent activation of c-Met downstream signalling 
compared to the stimulation with exogenous HGF, where concomitant receptor 
degradation may restrict c-Met–dependent signalling (Lemmon and Schlessinger, 2010). 
In future experiments we thus plan to examine c-Met activity and protein level in WT 
HEK293 cells over a longer incubation time with HGF.  
Alternatively, the different cellular responses to sustained c-Met activity may not derive 
from the signal magnitude. Is it instead possible that the respective c-Met–induced 
downstream signalling pathways rely on the activating stimulus? This merits further 
investigation. One could, for instance, envisage that active c-Met recruits a certain set of 
core effectors, yet accessory pathways may possibly be activated distinctively - 
depending on the mechanism of c-Met activation. It has already been shown in mice that 
c-Met–activating point-mutations cause the development of mutant-specific tumours 
(Graveel et al., 2004). This discovery already points to mutation-unique effector recruit-
ment by oncogenic c-Met. Similar effector selectivity may thus also arise from receptor 
activation by either HGF-stimulation or c-Met over-expression. In addition, the potential 
c-Met bias for certain downstream pathways may result from differential cellular 
locations of the activated receptor. It is already known that c-Met trafficking (Joffre et al., 
2011) as well as its signalling from early endosomes (Kermorgant and Parker, 2005) 
greatly contributes to receptor function and specificity. Moreover, highly invasive MDA-
MB-231 breast cancer cells have been found to localise a C-terminal c-Met–fragment to 
the nucleus, where it contributed to the invasiveness of the cells by a yet unknown 
mechanism. In contrast, low invasive MCF-7 breast cancer cells showed no nuclear 
localisation of c-Met (Matteucci et al., 2009). Although the mechanism remains elusive, 
these observations still underscore the significance of c-Met localisation for its effects on 
cellular behaviour. Future experiments will thus be aimed at investigating differences in 
c-Met localisation and signalling following either receptor over-expression or HGF-
stimulation.  
In line with our discovery that c-Met effects on cell invasion rely on the mechanism of 
activation is the finding that c-Met can be activated in a HGF-dependent and -indepen-
dent manner but via distinct mechanisms (Hui et al., 2009). While ligand-independent, 
integrin-mediated activation of c-Met required Src and FAK activation, the stimulation of 
c-Met by exogenous HGF did not rely on Src. It is thus conceivable that not only the 
activating mechanism may differ, but also the c-Met downstream signalling.  
 
In conclusion, we found that oncogenic c-Met activity results in differential cellular 
responses depending on the mechanism of receptor activation. HGF-mediated c-Met 
stimulation contributed to mesenchymal-type collective cell invasion, whereas c-Met 
over-expression may induce single cell migration with amoeboid characteristics. Our 
established 3D model will provide the possibility to examine in more detail the possible 
differences in the downstream signalling pathways that may arise from distinct c-Met–
activating stimuli. Moreover, with our 3D cell model we mimic the two major mechanisms 
that account for oncogenic c-Met activation in numerous human tumours. Our in vitro 
model is therefore a suitable and powerful tool to easily test new pharmacological 
agents targeting sustained c-Met signalling, while considering the distinct therapeutic 
challenges that may arise from oncogenic c-Met activity caused by either excessive 





2.2  RhoA, Handyman for c-Met–Mediated Cancer Cell Invasion 
 
In order to identify new regulatory proteins that accomplish oncogenic c-Met effects, we 
used the Tet-inducible HEK-Met cells, that undergo easily detectable morphological 
changes following sustained c-Met activation, and performed a high-throughput RNAi-
based cell spot microarray (Rantala et al., 2011). The most persuasive signalling 
cascade that was found to be crucial for the induction of the oncogenic rounding was the 
RhoA pathway. In fact, we found RhoA to be activated following Tet-induced c-Met over-
expression, and inhibition of RhoA, its effector kinase ROCK, as well as loss of RhoA by 
RNAi blocked the c-Met–induced morphological changes. In addition, also the myosin 
light chain (MLC) was found to be increasingly phosphorylated (II, Fig.1A), a finding 
which is consistent with RhoA/ROCK-stimulated cell contractility.  
RhoA activation following c-Met over-expression is in line with the proposed induction of 
an amoeboid invasion mode. Amoeboid migrating cells are characteristically roundish 
and exploit a propulsive RhoA-driven pushing migration mode (Friedl et al., 2001). 
Moreover, RhoA-stimulated contractility has been found to contribute to the disruption of 
cell-cell contacts (Zhong et al., 1997), and this may allow single cell migration out of the 
spheroid. In support of our results is also the recent finding that in human non-small cell 
lung (NSCL) carcinomas, c-Met over-expression correlates with RhoA and TIMP over-
expression in invasive specimens (Gumustekin et al., 2011). TIMP (Tissue Inhibitor 
Metalloproteinase) is a MMP-antagonist that prevents ECM proteolysis, and together 
with the earlier report that the NSCL carcinoma cell line H1299 preferentially migrates in 
the amoeboid mode (Carragher et al., 2006), these findings support our discovery that c-
Met over-expression initiates a RhoA-dependent, but MMP-independent amoeboid inva-
sion mode (Figure 8).   
 
Unexpectedly, RhoA/ROCK signalling was also crucial for the HGF-induced mesen-
chymal-type collective invasion of WT HEK293 cells. In other words, although HGF-
stimulated HEK293 cells employ a different migration strategy than HEK-Met cells, they 
still require RhoA activity for their invasion. This finding seems contradictory to the 
prevailing view that RhoA/ROCK signalling is dispensable for the mesenchymal 
migration mode (Pankova et al., 2010). However, extensive research on cell motility in 
3D matrices has led to the discovery of an increasing number of migration strategies, 
and the differences in the invasive behaviour of various cell types can possibly not be 
explained with only two classical migration modes (Mierke et al., 2008). Consistently, 
Poincloux and colleagues recently described the motility of MDA-MB-231 breast cancer 
cells in Matrigel. The cells combined characteristics from both the mesenchymal and the 
amoeboid migration mode (Poincloux et al., 2011). In addition, ROCK-dependent local 
matrix remodelling and deformation has also been shown to critically contribute to the 
migration of fibroblasts in 3D culture (Kim et al., 2006). Thus, mesenchymal cells seem 
to employ various strategies to locally remodel the microenvironment - one of them 
being RhoA activation.  
In addition, it is also conceivable that increased RhoA/ROCK activity has an impact on 
the cellular distribution of c-Met and thus on its specific downstream signalling. The 
spatial organisation and responsiveness of EGFR has been reported to be also 
dependent on the organisation of the actin cytoskeleton (Chung et al., 2010). Thus, 
RhoA/ROCK-mediated actin reorganisation may possibly affect also c-Met distribution 
and thereby enable the effector selectivity needed for the HGF-triggered mesenchymal 
migration mode. It remains a topic for further investigation whether the magnitude or 




stimulation and whether this putative difference accounts for the distinct morphological 
and migratory phenotypes in our cell models.   
Alternatively, the critical balance between RhoA and Rac1 activation, which controls the 
plasticity of tumour cell invasion, may be differentially shifted in our two cell models. The 
amoeboid migration mode requires high levels of active RhoA, but Rac1 activity needs 
to be low at the same time, as Rac1 counteracts RhoA-mediated actomyosin contractility 
(Sanz-Moreno et al., 2008). In addition, it has been found that Src promotes the mesen-
chymal migration of cancer cells, but is dispensable for the amoeboid-type motility 
(Carragher et al., 2006). More recently, it has been discovered that Src phosphorylates 
ROCK II on tyrosine Y722, thereby rendering ROCK inert to RhoA activation (Lee et al., 
2010). Together, these findings allow the hypothesis that sustained c-Met activity results 
in RhoA activation, irrespective whether the receptor was activated by ligand-stimulation 
or over-expression. However, Src may be specifically and selectively activated upon 
HGF-mediated c-Met–stimulation and thus inhibit the amoeboid invasion mode by 
inhibiting ROCK signalling. The consequent higher Rac1 activity in HGF-stimulated 
HEK293 cells may then promote the observed mesenchymal invasion mode. In order to 
test this hypothesis, we will analyse and compare the Rac1 activation status in our two 
cell models. 
 
In summary, our data indicate that RhoA is a key effector of sustained c-Met signalling, 
independent of the receptor-activating mechanism. Thus, RhoA/ROCK signalling contri-
butes to the broad migration-promoting effect of oncogenic c-Met, yet other accessory 
signalling pathways may then account for the different modes of migration.  
 
2.3 The Enigmatic Role of Hip1 in Tumourigenesis and Metastasis 
 
We found that sustained c-Met activation by either receptor over-expression or HGF 
stimulation resulted in decreased 1-integrin cell surface levels. We hence speculated 
that c-Met–initiated alteration of integrin trafficking is responsible for the onset of 
migration following oncogenic c-Met activation. 
Having this hypothesis in mind, the endocytic protein Huntingtin-interacting protein 1 
(Hip1) caught our attention in the hit list from our screen for novel c-Met effectors (II, 
Fig.4). Hip1 is an accessory protein in the clathrin-mediated endocytosis pathway, yet to 
date its actual function is still unclear (Gottfried et al., 2009). In neurons derived from 
Hip1 null mice, AMPA receptor failed to internalise upon ligand stimulation (Metzler et 
al., 2003). And also Gottfried and colleagues (2009) assigned a role for Hip1 during the 
early internalisation step in the abscission of clathrin-coated pits. In contrast, other 
studies have found that Hip1 over-expression in HEK293T cells prolonged EGFR activity 
following EGF-stimulation by blocking receptor targeting from the early endosomes to 
the lysosomal degradative pathway (Hyun and Ross, 2004). Recent work by the same 
group reported that Hip1 also retards the degradation of the SCF-activated receptor 
tyrosine kinase c-Kit in Merkel cell carcinomas of the skin (Ames et al., 2011). Moreover, 
owing to a correlation between Hip1 over-expression and concomitant elevated RTK 
activity in a number of carcinomas, they proposed that the Hip1 protein level may be 
used as a predictive marker for the presence and progression of some tumours to 
aggressive disease (Rao et al., 2003; Bradley et al., 2005; Ames et al., 2011).  
Because of the proposed functions of Hip1, we assumed that it may be recruited for the 
c-Met–stimulated integrin endocytosis. Moreover, as RTKs preferentially enter the cell 




Met and integrins. In line with this, we detected a strong co-localisation between the 
growth factor receptor and 1-integrins on endosomes following c-Met activation (II, 
Fig.1E). In accordance with the observations by Ross and colleagues (Ames et al., 
2011), one could also imagine that Hip1 protects activated c-Met receptor from degrada-
tion by targeting c-Met and integrins to the recycling pathway. But this hypothesis awaits 
further investigation. To date we do not yet know whether Hip1-silencing impedes c-Met 
internalisation or degradation.  
However, we found that in the absence of Hip1, both WT HEK293 and HEK-Met cells 
failed to induce 1-integrin internalisation following oncogenic c-Met activation. There-
fore, we propose a new function for the endocytic protein Hip1 in the internalisation of 
1-integrins downstream of activated c-Met. Consistently, a correlation between 
increased c-Met/HGF signalling and decreased 41-integrin (VLA-4) cell surface levels 
was recently discovered in B-chronic lymphocytic leukemia (Eksioglu-Demiralp et al., 
2011). Although in this study the researchers focused only on the consequent 
downstream signalling effects, it is conceivable that the elevated c-Met signalling had 
caused the diminished 41 surface levels via Hip1-mediated endocytosis. 
 
We also found that the loss of Hip1 prevented the HGF-stimulated mesenchymal 
invasion mode, which is known to depend on integrin engagement (Friedl and Gilmour, 
2009). Integrin-mediated adhesion is required whenever high traction forces are needed, 
for example during the crossing of the basement membrane (Renkawitz and Sixt, 2010). 
Therefore, the loss of Hip1 appears to impair the integrin-dependent mesenchymal 
invasion of WT HEK293 cells through Matrigel. This hypothesis is supported by our fin-
ding that also the presence of a 1-integrin function-blocking antibody prohibited HGF-
stimulated cell invasion into the matrix.  
Alternatively, it is also possible that the loss of Hip1 impairs the trafficking of the c-Met 
receptor itself. Thus, although c-Met is activated by HGF, it fails to promote oncogenic, 
pro-invasive signals from endosomes. The importance of the endosomal localisation for 
transforming c-Met signalling has recently been reported (Joffre et al., 2011). We 
therefore aim to examine possible alterations in the distribution of c-Met following Hip1 
loss.  
 
In contrast to the mesenchymal invasion mode, amoeboid-type cell motility, triggered by 
c-Met over-expression, depends on RhoA/ROCK signalling, but integrin engagement is 
thought to be dispensable (Friedl and Wolf, 2003). Consistently, we found that the 
presence of the 1 function-blocking antibody Mab13 had no impact on the initiation of 
the amoeboid phenotype in 3D Matrigel upon Tet-induction. Moreover, Hip1-silencing in 
HEK-Met cells did not prevent the induction of the amoeboid-like morphological changes 
following c-Met over-expression, while in the concomitant presence of either c-Met or 
ROCK inhibitor the fragmentation of the spheroids was inhibited. This indicated to us 
that Hip1-altered integrin trafficking does not play a role for the amoeboid-type invasion 
of cells in 3D Matrigel. However, under the conditions of our cell spot microarray screen, 
on planar cell culture plates, the loss of Hip1 did prevent the rounding of Tet-induced 
HEK-Met cells. The explanation for this seeming discrepancy is that amoeboid migration 
does not depend on integrin engagement in a 3D environment. However, on 2D sur-
faces, cell motility is only governed by a careful balance between adhesion and traction, 
and cell movement slows down if the adhesive strength is either too high or too low 
(Zaman et al., 2006). In other words, on 2D cell culture plates, cells rely only on 
adhesion and traction, and thus altered integrin trafficking by Hip1 has an impact on the 




ture and stiffness, and because amoeboid motility does not depend on integrin engage-
ment, Hip1-silencing has no apparent effect on the phenotype of HEK-Met cells in 3D 
Matrigel. However, although Hip1-mediated integrin trafficking has no influence on the 
amoeboid morphology, it may still influence the signalling events that account for this 
invasion mode. Further research will reveal whether Hip1 additionally contributes to the 
trafficking of c-Met and whether it allows collaborative signalling of integrins and c-Met 
(on endosomes?).  
 
3. The Role of the 51–ZO-1 Complex during Cell Migration 
 
In the third publication, we identified a new function for the tight junction protein ZO-1 in 
the regulation of cell migration (Figure 9). Following a migration-promoting stimulus, 
elevated PKC activity initiated the redistribution of ZO-1 from cell-cell contacts to the 
leading protrusion, where it, in cooperation with 51-integrin, maintained cell polarity 
and stimulated directionally persistent migration. The ominous role of the 51–ZO-1 
interaction for tumour invasion in vivo is underlined by the finding that the complex was 












Figure 9: ZO-1 and 51, a Migration-Promoting Duo.  
In immotile epithelial cells, ZO-1 is a component of tight junctions and 51-integrins 
mediate cell attachment to the basement membrane. However, following migration-
triggering impulses, high PKC levels result in 51–ZO-1 complex formation and facilitate 
integrin recycling from trapping vimentin (Vim) filaments. The 51–ZO-1 duo restricts 
Rac1 activation to the leading edge, thereby supporting cell polarity and directed migration.   
 
3.1 What Guides ZO-1 to the Leading Edge? 
 
We demonstrated with a biochemical ELISA assay in vitro that the integrin 5-subunit 
binds directly to the ZO-1 PDZ-domains via a non-canonical internal peptide sequence 
at its C-terminus (III, Fig.5A). We do not yet know which of the three PDZ-domains is 
crucial for the interaction. But more importantly, we found that in cells, ZO-1 required 
PKC-dependent phosphorylation on specific residues located between the first and the 
second PDZ-domain in order to interact with 51 at the lamellipodium (III, Fig.7). This 
finding provides a first indication of the mechanism that guides ZO-1 to the leading edge 
of the cell. We have found that integrin 51 was necessary to anchor ZO-1 at the 
lamellipodium, but PKC-dependent phosphorylation of the tight junction protein was 


























PKC creates binding epitopes, which recruit other cellular effector proteins that then 
guide ZO-1 from tight junctions to the lamellipodium in proximity to 51. The impor-
tance of ZO-1 phosphorylation for its cellular localisation has been proposed before 
(Taliana et al., 2005), yet the mechanism is still not known. Alternatively, it may be 
possible that ZO-1 phosphorylation is needed only for its release from tight junctions, yet 
other accessory proteins guide ZO-1 to the leading edge. It has recently been 
demonstrated that the Cdc42-activated MRCK kinase binds ZO-1 and directs the 
complex to the leading edge (Huo et al., 2011). However, also in this study the mole-
cular basis for the ZO-1 redistribution has not been elucidated.  
 
3.2  How Does the 51–ZO-1 Duo Maintain the Lamellipodium? 
 
Another question to be answered concerns the mechanism of how the 51–ZO-1 
complex promotes directed cell migration. Local Rac1 activation at the lamellipodium is 
required, but how is that achieved by the 51–ZO-1 interaction? One possible mecha-
nism involves the above mentioned work by Huo et al. (2011). They demonstrated that 
ZO-1 was required to anchor the Cdc42-MRCK complex at the leading lamellae. One 
could thus envisage that ZO-1 guides and ties this complex to 51-integrin. Moreover, 
Cdc42 has an established role for cell polarisation and local Rac1 activation (Iden and 
Collard, 2008). Thus, by the connective function of ZO-1, a multi-protein complex 
involving 51, Cdc42, and MRCK could allow for Rac1 activation at the advancing 
lamellipodium and consequently account for directed cell migration. In contrast, if ZO-1 
is absent, the Cdc42-MRCK complex is no longer distributed to the cell front, and 
instead Rac1 activation is stimulated throughout the cell. This would cause the formation 
of multiple protrusions and result in random motility (Pankov et al., 2005). In addition, it 
may also be possible that non-phosphorylated ZO-1, which is not engaged in tight 
junctions, recruits a Rac1-specific GAP protein. This putative Rac1-inhibitory interaction 
may be lost when ZO-1 is phosphorylated and thus complexed with Cdc42, MRCK, and 
51-integrin - or when ZO-1 is depleted by RNAi.  
An alternative mechanism of how the 51–ZO-1 duo may promote spatially restricted 
Rac1 activation comprises the Par-Tiam1 complex. The Par polarity complex has been 
found to target the Rac1-specific GEF Tiam1 to the leading edge and by subsequent 
local Rac1 activation to promote directed cell migration (Pegtel et al., 2007). 
Interestingly, the Par complex is crucial for the assembly of tight junctions, and its 
clustering with junctional adhesion molecules (JAMs) mediates the association with ZO-
1 (Ebnet et al., 2003). Phosphorylation-induced disassembly of cell-cell contacts (Lee 
and Daar, 2009) may hence cause the joint redistribution of the Par complex and ZO-1, 
accompanied by Tiam1, to 51-integrin at the leading edge.  
Yet another hypothesis involves the proteoglycan syndecan-4. This protein generally 
suppresses Rac1 activation, except at the leading cell edge, where its binding to fibro-
nectin promotes PKC-dependent Rac1 activation (Bass et al., 2007). But what mecha-
nism activates syndecan-4 specifically at the lamellipodium? We propose that a 
cooperative interaction between syndecan-4 and 51-integrin, possibly mediated by 
ZO-1, could contribute to the local Rac1 activation. In the event of lost ZO-1, matrix 
engagement at the plasma membrane could still lead to the activation of syndecan-4 
and thus to high levels of active Rac1, but this would no longer be restricted to the 




But whatever the molecular mechanism for the spatially restricted Rac1 activation by the 
51–ZO-1 complex is, it remains also unclear how this is restricted to the plasma mem-
brane at the leading edge. This process might possibly be controlled by the localisation 
of 51-integrin. Targeted recycling (e.g., resulting from elevated PKC activity) as well 
as enrichment of the integrin in specific lipid domains at the lamellipodium (Weisswange 
et al., 2005) may cooperatively contribute to 51 concentration at the cell front. More-
over, the second PDZ-domain of ZO-1 has been demonstrated to bind to PI(4,5)P2, 
PI(3,4,5)P3, and PI(3,4)P2 with low affinity (Meerschaert et al., 2009). The latter two 
phosphoinositides are specifically generated at the leading edge, and albeit the affinity 
of the PDZ-domain may not be strong enough to recruit ZO-1 to the plasma membrane, 
it may still have a modulating signalling or targeting role.  
 
3.3 Possible Role for ZO-1 in the Nucleus 
 
We also found a peculiar localisation of ZO-1 in the nucleus whenever PKC activity was 
impaired (II, Fig.6). ZO-1 has been acknowledged to be an itinerary protein with localisa-
tion-dependent functions (Polette et al., 2007). In stationary cells, ZO-1 is an important 
structural component of tight junctions. In addition, it sequesters the transcription factor 
ZONAB at intercellular contact sites, hence diminishing ZONAB nuclear levels and its 
ability to promote epithelial cell proliferation (Matter and Balda, 2007). The redistribution 
of ZO-1 to the nucleus has been described controversially, but there are studies repor-
ting a nuclear localisation of ZO-1 in migrating cells, where ZO-1 has been found to 
induce vimentin and MMP expression and to stimulate the invasiveness of carcinoma 
cells (Polette et al., 2007). Recent work by Remue and colleagues (2010) reported an 
association of the EMT-inducing transcription factor TAZ with the first PDZ-domain of 
ZO-1 and ZO-2. However, nuclear co-localisation with the transcription factor was pre-
dominantly observed for ZO-2, whereas ZO-1 interacted with TAZ mainly in the cytosol 
and only occasionally also in the nucleus (Remue et al., 2010). However, cell type-
related differences were observed, too. A recent publication reported a nuclear localisa-
tion of ZO-1 specifically for non-transformed cells (Belgiovine et al., 2011).  
 
Taken together, there is indeed controversial data on the nuclear localisation of ZO-1. 
Thus, cell type, differentiation state, and migratory circumstances may critically influence 
ZO-1 function in the nucleus. Our observation that ZO-1 shuttled to the nucleus in 
migrating cells following PKC depletion suggests that PKC may serve as a guardian of 
ZO-1 localisation and function. If the tight junction protein is released from cell-cell con-
tact sites, PKC phosphorylation labels ZO-1 for its 51-dependent migration-promo-
ting function at the leading cell edge - possibly by the recruitment of accessory shuttle 
proteins. In contrast, in the absence of PKC, ZO-1 is released from tight junctions, but 
redistributed to the nucleus, where it may influence EMT-inducing gene regulation in 
cooperation with certain transcription factors. In other words, ZO-1 may possibly contri-
bute to the invasiveness of carcinoma cells directly or indirectly, depending on the 




SUMMARY AND CONCLUSION 
 
At the beginning of this study, many questions were waiting to be answered. So we set 
out to explore novel regulatory mechanisms that urge malignant cells to roam. Cell 
migration is a highly complex process, which is carefully orchestrated in time and space, 
and which furthermore possesses great context- and cell type-dependency. In the 
course of this study, we succeeded to elucidate new, unconventional and unexpected 
signalling concepts, which broaden our basic knowledge of cell migration and invasion, 
and which may potentially help to discover novel therapeutic strategies in the future. 
 
First, we identified a non-catalytic function of the Ras GAP protein p120 for the traf-
ficking of integrins. By replacing the early endosomal Rab21 from the -cytodomain of 
1-integrins, p120 enables integrins to recycle back to the plasma membrane. The 
binding occurs via the GAP-domain of p120 and not through the canonical protein-
protein interaction domains at its N-terminus. In addition, we showed that also Rab21 
binds to the integrin tail in an unusual nucleotide-independent manner. Any intervention 
in this competitive mechanism results in imbalanced integrin trafficking and thus 
contributes to altered cell migration. We found that the loss of the tumour suppressor 
protein p120, as it occurs in many cancer types, may promote tumourigenesis not only 
by abolished control of mitogenic Ras signalling, but also by boosting the motility of 
cancer cells. 
Second, we shed light on migratory strategies of cells in a 3D matrix environment. We 
hypothesise that the same growth factor receptor, c-Met, induces distinct modes of cell 
motility following different mechanisms of activation. Most solid carcinomas have 
evolved a number of ligand-dependent and -independent tactics to avoid termination of 
c-Met signalling. For future therapeutic intervention it might thus be important to consider 
that paracrine/autocrine HGF-mediated c-Met stimulation promotes collective cell 
invasion with mesenchymal characteristics, whereas c-Met over-expression triggers 
amoeboid-type single cell migration. Both migration modes differ in their executing 
molecular machineries and may hence require differential treatment. 
Third, we discovered a molecular collaboration between two functionally divergent 
adhesion-associated molecules: integrins and the tight junction protein ZO-1. Following 
the breakdown of cell-cell contacts, these two proteins form a PKC-dependent complex, 
which possesses migration-promoting capabilities. The 51–ZO-1 interaction may thus 
be fatal, when cancer cells lose their intercellular junctions in the course of EMT and set 
out to conquer new metastatic niches.   
 
Together these findings add another sand grain of information to the vast beach of 
knowledge about cancer cell biology. However, with persistence and perseverance we 
may eventually accumulate a sufficient understanding in order to catch up with tumour 
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